Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 598 articles:
HTML format

Single Articles

    January 2020
  1. VAN DER LINDEN M, Imohl M, Perniciaro S
    Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
    PLoS One. 2020;15:e0228126.
    PubMed     Abstract available

  2. PATIC A, Strbac M, Petrovic V, Milosevic V, et al
    Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.
    PLoS One. 2020;15:e0227413.
    PubMed     Abstract available

  3. LU C, Song G, Beale K, Yan J, et al
    Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines.
    PLoS One. 2020;15:e0216260.
    PubMed     Abstract available

  4. MUPERE E, Babikako HM, Okaba-Kayom V, Mutyaba RB, et al
    Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda.
    PLoS One. 2020;15:e0218239.
    PubMed     Abstract available

  5. TOBIN GJ, Tobin JK, Gaidamakova EK, Wiggins TJ, et al
    A novel gamma radiation-inactivated sabin-based polio vaccine.
    PLoS One. 2020;15:e0228006.
    PubMed     Abstract available

  6. ZHAO LP, Fiore-Gartland A, Carpp LN, Cohen KW, et al
    Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
    PLoS One. 2020;15:e0226803.
    PubMed     Abstract available

  7. FELDMAN C, Dlamini SK, Madhi SA, Meiring S, et al
    The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults.
    PLoS One. 2020;15:e0227945.
    PubMed     Abstract available

  8. FRIEDRICH F, Valadao MC, Brum M, Comaru T, et al
    Impact of maternal dTpa vaccination on the incidence of pertussis in young infants.
    PLoS One. 2020;15:e0228022.
    PubMed     Abstract available

  9. DUFOUR C, Fournier V, Giovenazzo P
    The impact of lowbush blueberry (Vaccinium angustifolium Ait.) and cranberry (Vaccinium macrocarpon Ait.) pollination on honey bee (Apis mellifera L.) colony health status.
    PLoS One. 2020;15:e0227970.
    PubMed     Abstract available

  10. NAIDU SK, Nabi R, Cheemarla NR, Stanfield BA, et al
    Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.
    PLoS One. 2020;15:e0228252.
    PubMed     Abstract available

  11. DEBELLUT F, Jaber S, Bouzya Y, Sabbah J, et al
    Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
    PLoS One. 2020;15:e0228506.
    PubMed     Abstract available

  12. NONGNUCH A, Ngampongpan W, Srichatrapimuk S, Wongsa A, et al
    Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
    PLoS One. 2020;15:e0227719.
    PubMed     Abstract available

  13. AI CE, Steele M, Lopman B
    Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study.
    PLoS One. 2020;15:e0228942.
    PubMed     Abstract available

  14. BAQUI AH, McCollum ED, Mahmud A, Roy A, et al
    Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh.
    PLoS One. 2020;15:e0228799.
    PubMed     Abstract available

  15. JANMOHAMMADI A, Sheikhi N, Nazarpak HH, Nikbakht Brujeni G, et al
    Effects of vaccination on acute-phase protein response in broiler chicken.
    PLoS One. 2020;15:e0229009.
    PubMed     Abstract available

  16. LIU X, Liang B, Liu X, Amaro-Carambot E, et al
    Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.
    PLoS One. 2020;15:e0228572.
    PubMed     Abstract available

  17. LI XH, Vance GM, Cartwright J, Cao JP, et al
    Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs.
    PLoS One. 2020;15:e0229542.
    PubMed     Abstract available

  18. HU W, He M, Li L
    HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
    PLoS One. 2020;15:e0229327.
    PubMed     Abstract available

  19. KLEIN NP, Fireman B, Goddard K, Zerbo O, et al
    Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
    PLoS One. 2020;15:e0229279.
    PubMed     Abstract available

  20. MILHAU N, Almouazen E, Bouteille S, Hellel-Bourtal I, et al
    In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus.
    PLoS One. 2020;15:e0229121.
    PubMed     Abstract available

  21. MUNUSAMY PONNAN S, Hayes P, Fernandez N, Thiruvengadam K, et al
    Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India.
    PLoS One. 2020;15:e0229461.
    PubMed     Abstract available

  22. SARLI M, Novoa MB, Mazzucco MN, Signorini ML, et al
    A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
    PLoS One. 2020;15:e0229301.
    PubMed     Abstract available

  23. VIRNIK K, Rosati M, Medvedev A, Scanlan A, et al
    Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
    PLoS One. 2020;15:e0228163.
    PubMed     Abstract available

  24. JIMENEZ AV, Mesoudi A, Tehrani JJ
    No evidence that omission and confirmation biases affect the perception and recall of vaccine-related information.
    PLoS One. 2020;15:e0228898.
    PubMed     Abstract available

  25. FAKHRI O, Devlin JM, Browning GF, Vaz PK, et al
    Genomic recombination between infectious laryngotracheitis vaccine strains occurs under a broad range of infection conditions in vitro and in ovo.
    PLoS One. 2020;15:e0229082.
    PubMed     Abstract available

  26. CHAPARRO RM, Rodriguez B, Maza Y, Moyano D, et al
    Factors associated with hindering the acceptance of HPV vaccination among caregivers - A cross-sectional study in Argentina.
    PLoS One. 2020;15:e0229793.
    PubMed     Abstract available

  27. JANMOHAMMADI A, Sheikhi N, Nazarpak HH, Nikbakht Brujeni G, et al
    Correction: Effects of vaccination on acute-phase protein response in broiler chicken.
    PLoS One. 2020;15:e0230949.
    PubMed     Abstract available

  28. CHIRKOVA T, Ha B, Rimawi BH, Oomens AGP, et al
    In vitro model for the assessment of human immune responses to subunit RSV vaccines.
    PLoS One. 2020;15:e0229660.
    PubMed     Abstract available

  29. COSTA AS, Gomes JM, Germani ACCG, da Silva MR, et al
    Knowledge gaps and acquisition about HPV and its vaccine among Brazilian medical students.
    PLoS One. 2020;15:e0230058.
    PubMed     Abstract available

  30. HJALMARSDOTTIR MA, Haraldsson G, Quirk SJ, Haraldsson A, et al
    Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.
    PLoS One. 2020;15:e0230332.
    PubMed     Abstract available

  31. ZHANG J, He J, Li J, Zhou Q, et al
    The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis.
    PLoS One. 2020;15:e0230381.
    PubMed     Abstract available

  32. HAO S, Wang C, Liu S, He J, et al
    HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
    PLoS One. 2020;15:e0230640.
    PubMed     Abstract available

  33. OGAWA T, Inoue T, Kasahara K, Konishi M, et al
    Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    PLoS One. 2020;15:e0230329.
    PubMed     Abstract available

  34. LAPUENTE D, Stab V, Storcksdieck Genannt Bonsmann M, Maaske A, et al
    Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine.
    PLoS One. 2020;15:e0231138.
    PubMed     Abstract available

  35. O'CONNELL CM, Jasperse B, Hagen CJ, Titong A, et al
    Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
    PLoS One. 2020;15:e0230711.
    PubMed     Abstract available

  36. LI AJ, Tabu C, Shendale S, Okoth PO, et al
    Qualitative insights into reasons for missed opportunities for vaccination in Kenyan health facilities.
    PLoS One. 2020;15:e0230783.
    PubMed     Abstract available

  37. SCHRIJVERS-GONLAG M, Skarpe C, Andreassen HP
    Influence of light availability and soil productivity on insect herbivory on bilberry (Vaccinium myrtillus L.) leaves following mammalian herbivory.
    PLoS One. 2020;15:e0230509.
    PubMed     Abstract available

  38. LAURETTI-FERREIRA F, Silva PLD, Alcantara NM, Silva BF, et al
    New strategies for Leptospira vaccine development based on LPS removal.
    PLoS One. 2020;15:e0230460.
    PubMed     Abstract available

  39. TUCKERMAN J, Crawford NW, Marshall HS
    Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination.
    PLoS One. 2020;15:e0230425.
    PubMed     Abstract available

  40. BAHEMUKA UM, Abaasa A, Seeley J, Byaruhanga M, et al
    Feasibility of establishing an HIV vaccine preparedness cohort in a population of the Uganda Police Force: Lessons learnt from a prospective study.
    PLoS One. 2020;15:e0231640.
    PubMed     Abstract available

  41. LEUKER C, Samartzidis L, Hertwig R, Pleskac TJ, et al
    When money talks: Judging risk and coercion in high-paying clinical trials.
    PLoS One. 2020;15:e0227898.
    PubMed     Abstract available

  42. ACEVEDO-VILLANUEVA KY, Lester B, Renu S, Han Y, et al
    Efficacy of chitosan-based nanoparticle vaccine administered to broiler birds challenged with Salmonella.
    PLoS One. 2020;15:e0231998.
    PubMed     Abstract available

  43. LEE MF, Chen YH, Song PP, Lin TM, et al
    Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy.
    PLoS One. 2020;15:e0232042.
    PubMed     Abstract available

  44. ADAM A, Fusheini A
    Knowledge, risk of infection, and vaccination status of hepatitis B virus among rural high school students in Nanumba North and South Districts of Ghana.
    PLoS One. 2020;15:e0231930.
    PubMed     Abstract available

  45. OPANDA S, Bulimo W, Gachara G, Ekuttan C, et al
    Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene.
    PLoS One. 2020;15:e0228029.
    PubMed     Abstract available

  46. STEFANOFF P, Sobierajski T, Bulinska-Stangrecka H, Augustynowicz E, et al
    Exploring factors improving support for vaccinations among Polish primary care physicians.
    PLoS One. 2020;15:e0232722.
    PubMed     Abstract available

  47. SARKER AR, Islam Z, Sultana M, Sheikh N, et al
    Willingness to pay for oral cholera vaccines in urban Bangladesh.
    PLoS One. 2020;15:e0232600.
    PubMed     Abstract available

  48. PARZYCH EM, Miura K, Long CA, Burns JM Jr, et al
    Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
    PLoS One. 2020;15:e0232355.
    PubMed     Abstract available

  49. POTLURI R, Kumar A, Maheshwari V, Smith C, et al
    Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis.
    PLoS One. 2020;15:e0230406.
    PubMed     Abstract available

  50. GODFREY O, Zhang W, Amponsem-Boateng C, Bonney Oppong T, et al
    Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis.
    PLoS One. 2020;15:e0232113.
    PubMed     Abstract available

  51. RIMAL S, Ojha KC, Chaisowwong W, Shah Y, et al
    Detection of virus-neutralising antibodies and associated factors against rabies in the vaccinated household dogs of Kathmandu Valley, Nepal.
    PLoS One. 2020;15:e0231967.
    PubMed     Abstract available

  52. RYYTI R, Hamalainen M, Peltola R, Moilanen E, et al
    Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation on metabolic and inflammatory adverse effects induced by high-fat diet in a mouse model of obesity.
    PLoS One. 2020;15:e0232605.
    PubMed     Abstract available

  53. CUMMINGS CL, Kong WY, Orminski J
    A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore.
    PLoS One. 2020;15:e0232472.
    PubMed     Abstract available

  54. MANSILLA FC, Turco CS, Miraglia MC, Bessone FA, et al
    The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.
    PLoS One. 2020;15:e0232782.
    PubMed     Abstract available

  55. BENNETT DE, Meyler KL, Cafferkey MT, Cunney RJ, et al
    Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.
    PLoS One. 2020;15:e0228629.
    PubMed     Abstract available

  56. LIM W, Zhang P
    Herd immunity and a vaccination game: An experimental study.
    PLoS One. 2020;15:e0232652.
    PubMed     Abstract available

  57. ITO H, Nishimura H, Kisu T, Hagiwara H, et al
    Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.
    PLoS One. 2020;15:e0233001.
    PubMed     Abstract available

  58. SPRYGIN A, Pestova Y, Bjadovskaya O, Prutnikov P, et al
    Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease.
    PLoS One. 2020;15:e0232584.
    PubMed     Abstract available

  59. NAMAKULA R, de Bree LCJ, A Tvedt TH, Netea MG, et al
    Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and beta-glucan.
    PLoS One. 2020;15:e0229287.
    PubMed     Abstract available

  60. CASTRO JT, Oliveira GS, Nishigasako MA, Debrie AS, et al
    Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
    PLoS One. 2020;15:e0228055.
    PubMed     Abstract available

  61. CREPEY P, Redondo E, Diez-Domingo J, Ortiz de Lejarazu R, et al
    From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
    PLoS One. 2020;15:e0233526.
    PubMed     Abstract available

  62. MUNGWIRA RG, Guillard C, Saldana A, Okabe N, et al
    Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries.
    PLoS One. 2020;15:e0233334.
    PubMed     Abstract available

  63. CHANGOLKAR S, Rewley J, Balachandran M, Rareshide CAL, et al
    Phenotyping physician practice patterns and associations with response to a nudge in the electronic health record for influenza vaccination: A quasi-experimental study.
    PLoS One. 2020;15:e0232895.
    PubMed     Abstract available

  64. MBOUMBA BOUASSA RS, Pere H, Gubavu C, Prazuck T, et al
    Serum and cervicovaginal IgG immune responses against alpha7 and alpha9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.
    PLoS One. 2020;15:e0233084.
    PubMed     Abstract available

  65. SANCHEZ JN, Hudgens BR
    Vaccination and monitoring strategies for epidemic prevention and detection in the Channel Island fox (Urocyon littoralis).
    PLoS One. 2020;15:e0232705.
    PubMed     Abstract available

    January 2019
  66. ZEBERTAVAGE L, Bambina S, Shugart J, Alice A, et al
    A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
    PLoS One. 2019;14:e0209153.
    PubMed     Abstract available

  67. HODGINS B, Pillet S, Landry N, Ward BJ, et al
    A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities.
    PLoS One. 2019;14:e0210009.
    PubMed     Abstract available

  68. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0210081.
    PubMed     Abstract available

  69. PERNICIARO S, Imohl M, Fitzner C, van der Linden M, et al
    Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany.
    PLoS One. 2019;14:e0210278.
    PubMed     Abstract available

  70. LEE YY, Wang Z
    Facilitators and barriers for healthcare providers to recommend HPV vaccination to attendees of public sexually transmitted diseases clinics in Hong Kong, China.
    PLoS One. 2019;14:e0209942.
    PubMed     Abstract available

  71. ATCHESON E, Bauza K, Reyes-Sandoval A
    A probabilistic model of pre-erythrocytic malaria vaccine combination in mice.
    PLoS One. 2019;14:e0209028.
    PubMed     Abstract available

  72. NYARI S, Booth R, Quigley BL, Waugh CA, et al
    Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
    PLoS One. 2019;14:e0210245.
    PubMed     Abstract available

  73. YOU JHS, Ming WK, Tsang OT, Chan PK, et al
    Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.
    PLoS One. 2019;14:e0210005.
    PubMed     Abstract available

  74. KISLAYA I, Rodrigues AP, Sousa-Uva M, Gomez V, et al
    Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
    PLoS One. 2019;14:e0209428.
    PubMed     Abstract available

  75. WORMSBECKER AE, Johnson C, Bourns L, Harris T, et al
    Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
    PLoS One. 2019;14:e0210833.
    PubMed     Abstract available

  76. BAHEMUKA UM, Abaasa A, Ruzagira E, Lindan C, et al
    Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda.
    PLoS One. 2019;14:e0198460.
    PubMed     Abstract available

  77. OGBUANU IU, Li AJ, Anya BM, Tamadji M, et al
    Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology.
    PLoS One. 2019;14:e0210648.
    PubMed     Abstract available

  78. ROSANOWSKI SM, Carpenter TE, Adamson D, Rogers CW, et al
    An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country.
    PLoS One. 2019;14:e0210885.
    PubMed     Abstract available

  79. PRIMO ME, Thompson CS, Valentini BS, Sarli M, et al
    Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.
    PLoS One. 2019;14:e0211149.
    PubMed     Abstract available

  80. HOULE SKD, Eurich DT
    Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada.
    PLoS One. 2019;14:e0211006.
    PubMed     Abstract available

  81. CUI J, O'Connell CM, Costa A, Pan Y, et al
    A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0208801.
    PubMed     Abstract available

  82. ROCKSTROH JK, Asmuth D, Pantaleo G, Clotet B, et al
    Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
    PLoS One. 2019;14:e0210965.
    PubMed     Abstract available

  83. CASAL J, Saegerman C, Bertagnoli S, Meyer G, et al
    A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France.
    PLoS One. 2019;14:e0210317.
    PubMed     Abstract available

  84. ESPANA G, Hogea C, Guignard A, Ten Bosch QA, et al
    Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms.
    PLoS One. 2019;14:e0210041.
    PubMed     Abstract available

  85. YUN JW, Choi MJ, Shin GS, Lim JO, et al
    Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea.
    PLoS One. 2019;14:e0209643.
    PubMed     Abstract available

  86. MARTINEZ L, Milanic M, Malaina I, Alvarez C, et al
    Weighted lambda superstrings applied to vaccine design.
    PLoS One. 2019;14:e0211714.
    PubMed     Abstract available

  87. KIM HW, Lee HY, Kim SE, Ahn HY, et al
    Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea.
    PLoS One. 2019;14:e0211475.
    PubMed     Abstract available

  88. LEVY C, Varon E, Ouldali N, Wollner A, et al
    Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.
    PLoS One. 2019;14:e0211712.
    PubMed     Abstract available

  89. CHAKRABARTI A, Grepin KA, Helleringer S
    The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
    PLoS One. 2019;14:e0212049.
    PubMed     Abstract available

  90. MEDISE BE, Soedjatmiko S, Rengganis I, Gunardi H, et al
    Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
    PLoS One. 2019;14:e0211784.
    PubMed     Abstract available

  91. WILDE S, Jiang Y, Tafoya AM, Horsman J, et al
    Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.
    PLoS One. 2019;14:e0197721.
    PubMed     Abstract available

  92. CUI J, O'Connell CM, Costa A, Pan Y, et al
    Correction: A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNgamma responses against several genotype 2 strains.
    PLoS One. 2019;14:e0213091.
    PubMed     Abstract available

  93. REUSCHEL E, Jilg W, Seelbach-Goebel B, Deml L, et al
    Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    PLoS One. 2019;14:e0212800.
    PubMed     Abstract available

  94. GUERRA-MAUPOME M, Vang DX, McGill JL
    Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    PLoS One. 2019;14:e0212751.
    PubMed     Abstract available

  95. ALCOLEA PJ, Alonso A, Esteban A, Peris P, et al
    IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.
    PLoS One. 2019;14:e0212136.
    PubMed     Abstract available

  96. RICHTER L, Schmid D, Kanitz EE, Zwazl I, et al
    Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    PLoS One. 2019;14:e0212957.
    PubMed     Abstract available

  97. NGOCHO JS, Magoma B, Olomi GA, Mahande MJ, et al
    Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.
    PLoS One. 2019;14:e0212295.
    PubMed     Abstract available

  98. BOULTON ML, Carlson BF, Wagner AL, Porth JM, et al
    Vaccination timeliness among newborns and infants in Ethiopia.
    PLoS One. 2019;14:e0212408.
    PubMed     Abstract available

  99. TUMIOTTO C, Alves BM, Recordon-Pinson P, Jourdain M, et al
    Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
    PLoS One. 2019;14:e0212347.
    PubMed     Abstract available

  100. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    PubMed     Abstract available

  101. KELLY JD, Worden L, Wannier SR, Hoff NA, et al
    Projections of Ebola outbreak size and duration with and without vaccine use in Equateur, Democratic Republic of Congo, as of May 27, 2018.
    PLoS One. 2019;14:e0213190.
    PubMed     Abstract available

  102. SRIVASTAV A, O'Halloran A, Lu PJ, Williams WW, et al
    Vaccination differences among U.S. adults by their self-identified sexual orientation, National Health Interview Survey, 2013-2015.
    PLoS One. 2019;14:e0213431.
    PubMed     Abstract available

  103. KIM HJ, Son HS, Lee SW, Yoon Y, et al
    Efficient expression of enterovirus 71 based on virus-like particles vaccine.
    PLoS One. 2019;14:e0210477.
    PubMed     Abstract available

  104. VAN DER WEELE P, Breeuwsma M, Donken R, van Logchem E, et al
    Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.
    PLoS One. 2019;14:e0212927.
    PubMed     Abstract available

  105. DABRAL N, Burcham GN, Jain-Gupta N, Sriranganathan N, et al
    Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    PLoS One. 2019;14:e0213587.
    PubMed     Abstract available

  106. MOHAMMED H, McMillan M, Roberts CT, Marshall HS, et al
    A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.
    PLoS One. 2019;14:e0214538.
    PubMed     Abstract available

  107. THILAKARATHNE DS, Coppo MJC, Hartley CA, Diaz-Mendez A, et al
    Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    PLoS One. 2019;14:e0213866.
    PubMed     Abstract available

  108. MUNUSAMY PONNAN S, Pattabiram S, Thiruvengadam K, Goyal R, et al
    Induction and maintenance of bi-functional (IFN-gamma + IL-2+ and IL-2+ TNF-alpha+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2019;14:e0213911.
    PubMed     Abstract available

  109. MWANGOME M, Ngari M, Bwahere P, Kabore P, et al
    Anthropometry at birth and at age of routine vaccination to predict mortality in the first year of life: A birth cohort study in BukinaFaso.
    PLoS One. 2019;14:e0213523.
    PubMed     Abstract available

  110. BERNSTEIN DI, Cardin RD, Pullum DA, Bravo FJ, et al
    Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.
    PLoS One. 2019;14:e0213401.
    PubMed     Abstract available

  111. WIBABARA Y, Banura C, Kalyango J, Karamagi C, et al
    Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences.
    PLoS One. 2019;14:e0214732.
    PubMed     Abstract available

  112. MAENETJE P, Lindan C, Makkan H, Chetty-Makkan CM, et al
    HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa.
    PLoS One. 2019;14:e0214786.
    PubMed     Abstract available

  113. VUPPUTURI S, Rubenstein KB, Derus AJ, Loftus BC, et al
    Factors contributing to racial disparities in influenza vaccinations.
    PLoS One. 2019;14:e0213972.
    PubMed     Abstract available

  114. MESA KA, Yu B, Wrin T, Petropoulos CJ, et al
    Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
    PLoS One. 2019;14:e0213409.
    PubMed     Abstract available

  115. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey.
    PLoS One. 2019;14:e0215125.
    PubMed     Abstract available

  116. WILLIAMS LBA, Fry LM, Herndon DR, Franceschi V, et al
    A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    PLoS One. 2019;14:e0215605.
    PubMed     Abstract available

  117. MOONSAMY S, Suchard M, Madhi SA
    Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.
    PLoS One. 2019;14:e0215079.
    PubMed     Abstract available

  118. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    PubMed     Abstract available

  119. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.
    PLoS One. 2019;14:e0215321.
    PubMed     Abstract available

  120. LOUBET P, Nguyen C, Burnet E, Launay O, et al
    Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives.
    PLoS One. 2019;14:e0215251.
    PubMed     Abstract available

  121. BERTOLDO G, Pesce A, Pepe A, Pelullo CP, et al
    Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy.
    PLoS One. 2019;14:e0215978.
    PubMed     Abstract available

  122. PEASAH SK, Meltzer MI, Vu M, Moulia DL, et al
    Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    PLoS One. 2019;14:e0213499.
    PubMed     Abstract available

  123. YUAN Q, Wang F, Zheng H, Zhang G, et al
    Hepatitis B vaccination coverage among health care workers in China.
    PLoS One. 2019;14:e0216598.
    PubMed     Abstract available

  124. MASONOU T, Hokey DA, Lahey T, Halliday A, et al
    CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    PLoS One. 2019;14:e0217091.
    PubMed     Abstract available

  125. VERHEES RAF, Thijs C, Ambergen T, Dinant GJ, et al
    Influenza vaccination in the elderly: 25 years follow-up of a randomized controlled trial. No impact on long-term mortality.
    PLoS One. 2019;14:e0216983.
    PubMed     Abstract available

  126. SEGURA M, Lopez-Gigosos R, Mariscal-Lopez E, Gutierrez-Bedmar M, et al
    Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017.
    PLoS One. 2019;14:e0217588.
    PubMed     Abstract available

  127. ALFONSO VH, Bratcher A, Ashbaugh H, Doshi R, et al
    Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo.
    PLoS One. 2019;14:e0217426.
    PubMed     Abstract available

  128. PILLET S, Couillard J, Trepanier S, Poulin JF, et al
    Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and >/=50 years old adults.
    PLoS One. 2019;14:e0216533.
    PubMed     Abstract available

  129. BIDDLECOME A, Habte HH, McGrath KM, Sambanthamoorthy S, et al
    Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles.
    PLoS One. 2019;14:e0215031.
    PubMed     Abstract available

  130. MBOUMBA BOUASSA RS, Nodjikouambaye ZA, Sadjoli D, Adawaye C, et al
    High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
    PLoS One. 2019;14:e0217486.
    PubMed     Abstract available

  131. KOS S, Lopes A, Preat V, Cemazar M, et al
    Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.
    PLoS One. 2019;14:e0217762.
    PubMed     Abstract available

  132. TEMBO T, Simuyandi M, Chiyenu K, Sharma A, et al
    Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
    PLoS One. 2019;14:e0215972.
    PubMed     Abstract available

  133. SAGIYEV Z, Berdibekov A, Bolger T, Merekenova A, et al
    Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015.
    PLoS One. 2019;14:e0218366.
    PubMed     Abstract available

  134. LUNA BM, Nielsen TB, Cheng B, Pantapalangkoor P, et al
    Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
    PLoS One. 2019;14:e0217439.
    PubMed     Abstract available

  135. WANGMO K, Laven R, Cliquet F, Wasniewski M, et al
    Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan.
    PLoS One. 2019;14:e0209946.
    PubMed     Abstract available

  136. SABAHELZAIN MM, Moukhyer M, Dube E, Hardan A, et al
    Towards a further understanding of measles vaccine hesitancy in Khartoum state, Sudan: A qualitative study.
    PLoS One. 2019;14:e0213882.
    PubMed     Abstract available

  137. RAGHAVA MOHAN V, Raj S, Dhingra MS, Aloysia D'Cor N, et al
    Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
    PLoS One. 2019;14:e0218033.
    PubMed     Abstract available

  138. KANG HJ, Chu KB, Lee DH, Lee SH, et al
    Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs.
    PLoS One. 2019;14:e0216871.
    PubMed     Abstract available

  139. DESHEVA Y, Leontieva G, Kramskaya T, Grabovskaya KB, et al
    Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections.
    PLoS One. 2019;14:e0218544.
    PubMed     Abstract available

  140. Retraction: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    PLoS One. 2019;14:e0218050.

  141. WU HH, Chang YY, Kuo SC, Chen YT, et al
    Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    PLoS One. 2019;14:e0219172.
    PubMed     Abstract available

  142. OBIRI-YEBOAH D, Awuku YA, Adjei G, Cudjoe O, et al
    Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana.
    PLoS One. 2019;14:e0219148.
    PubMed     Abstract available

  143. STENZEL T, Dziewulska D, Smialek M, Tykalowski B, et al
    Comparison of the immune response to vaccination with pigeon circovirus recombinant capsid protein (PiCV rCP) in pigeons uninfected and subclinically infected with PiCV.
    PLoS One. 2019;14:e0219175.
    PubMed     Abstract available

  144. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental pneumococcal vaccine for mucosal immunization.
    PLoS One. 2019;14:e0218679.
    PubMed     Abstract available

  145. ADAMU AA, Uthman OA, Gadanya MA, Adetokunboh OO, et al
    A multilevel analysis of the determinants of missed opportunities for vaccination among children attending primary healthcare facilities in Kano, Nigeria: Findings from the pre-implementation phase of a collaborative quality improvement programme.
    PLoS One. 2019;14:e0218572.
    PubMed     Abstract available

  146. MIYASHITA Y, Ishikawa K, Fukushima Y, Kouwaki T, et al
    Immune-regulatory microRNA expression levels within circulating extracellular vesicles correspond with the appearance of local symptoms after seasonal flu vaccination.
    PLoS One. 2019;14:e0219510.
    PubMed     Abstract available

  147. KIM MH, Kim HJ, Chang J
    Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    PLoS One. 2019;14:e0220196.
    PubMed     Abstract available

  148. ALESSANDRINI V, Anselem O, Girault A, Mandelbrot L, et al
    Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?
    PLoS One. 2019;14:e0220705.
    PubMed     Abstract available

  149. BRICOUT H, Torcel-Pagnon L, Lecomte C, Almas MF, et al
    Determinants of shingles vaccine acceptance in the United Kingdom.
    PLoS One. 2019;14:e0220230.
    PubMed     Abstract available

  150. VAN DER LINDEN M, Imohl M, Perniciaro S
    Limited indirect effects of an infant pneumococcal vaccination program in an aging population.
    PLoS One. 2019;14:e0220453.
    PubMed     Abstract available

  151. ANDRESEN AMS, Lutfi E, Ruyter B, Berge G, et al
    Interaction between dietary fatty acids and genotype on immune response in Atlantic salmon (Salmo salar) after vaccination: A transcriptome study.
    PLoS One. 2019;14:e0219625.
    PubMed     Abstract available

  152. SCHMEDT N, Schiffner-Rohe J, Sprenger R, Walker J, et al
    Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.
    PLoS One. 2019;14:e0220848.
    PubMed     Abstract available

  153. BENNASRALLAH C, Kacem M, Dhouib W, Zemni I, et al
    BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0219991.
    PubMed     Abstract available

  154. CAMPBELL ZA, Thumbi SM, Marsh TL, Quinlan MB, et al
    Why isn't everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzania.
    PLoS One. 2019;14:e0220963.
    PubMed     Abstract available

  155. JEONG S, Jang EJ, Jo J, Jang S, et al
    Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis.
    PLoS One. 2019;14:e0220910.
    PubMed     Abstract available

  156. WOLFSON LJ, Daniels VJ, Pillsbury M, Kurugol Z, et al
    Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
    PLoS One. 2019;14:e0220921.
    PubMed     Abstract available

  157. FRALEIGH NL, Oliva R, Lewicky JD, Martel AL, et al
    Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
    PLoS One. 2019;14:e0221708.
    PubMed     Abstract available

  158. DRURY RE, Pollard AJ, O'Connor D
    The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies.
    PLoS One. 2019;14:e0221143.
    PubMed     Abstract available

  159. MAREFIAW TA, Yenesew MA, Mihirete KM
    Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.
    PLoS One. 2019;14:e0218470.
    PubMed     Abstract available

  160. FERRERAS E, Matapo B, Chizema-Kawesha E, Chewe O, et al
    Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    PLoS One. 2019;14:e0219040.
    PubMed     Abstract available

  161. BITSOUNI V, Lycett S, Opriessnig T, Doeschl-Wilson A, et al
    Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs.
    PLoS One. 2019;14:e0220738.
    PubMed     Abstract available

  162. JUSTWAN F, Baumgaertner B, Carlisle JE, Carson E, et al
    The effect of trust and proximity on vaccine propensity.
    PLoS One. 2019;14:e0220658.
    PubMed     Abstract available

  163. NAKATUDDE I, Rujumba J, Namiiro F, Sam A, et al
    Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda.
    PLoS One. 2019;14:e0221902.
    PubMed     Abstract available

  164. KRAMSKAYA T, Leontieva G, Desheva Y, Grabovskaya K, et al
    Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice.
    PLoS One. 2019;14:e0222148.
    PubMed     Abstract available

  165. VON MOLLENDORF C, La Vincente S, Ulziibayar M, Suuri B, et al
    Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016.
    PLoS One. 2019;14:e0222423.
    PubMed     Abstract available

  166. CHAN JA, Wetzel D, Reiling L, Miura K, et al
    Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
    PLoS One. 2019;14:e0221733.
    PubMed     Abstract available

  167. ISLAM MA, Neuhoff C, Aqter Rony S, Grosse-Brinkhaus C, et al
    PBMCs transcriptome profiles identified breed-specific transcriptome signatures for PRRSV vaccination in German Landrace and Pietrain pigs.
    PLoS One. 2019;14:e0222513.
    PubMed     Abstract available

  168. BRAEYE T, Bauchau V, Sturkenboom M, Emborg HD, et al
    Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project.
    PLoS One. 2019;14:e0222296.
    PubMed     Abstract available

  169. CARTER C, Houser KV, Yamshchikov GV, Bellamy AR, et al
    Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
    PLoS One. 2019;14:e0222178.
    PubMed     Abstract available

  170. MACICAME I, Bhatt N, Matavele Chissumba R, Eller LA, et al
    HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique.
    PLoS One. 2019;14:e0221682.
    PubMed     Abstract available

  171. SISTERE-ORO M, Lopez-Serrano S, Veljkovic V, Pina-Pedrero S, et al
    DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
    PLoS One. 2019;14:e0222201.
    PubMed     Abstract available

  172. DIAZ-GARCIA L, Rodriguez-Bonilla L, Phillips M, Lopez-Hernandez A, et al
    Comprehensive analysis of the internal structure and firmness in American cranberry (Vaccinium macrocarpon Ait.) fruit.
    PLoS One. 2019;14:e0222451.
    PubMed     Abstract available

  173. KRAFT C, Hennies R, Dreckmann K, Noguera M, et al
    Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity.
    PLoS One. 2019;14:e0223060.
    PubMed     Abstract available

  174. MONAMELE CG, Munshili Njifon HL, Vernet MA, Njankouo MR, et al
    Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2019;14:e0210119.
    PubMed     Abstract available

  175. COETZER A, Gwenhure L, Makaya P, Markotter W, et al
    Epidemiological aspects of the persistent transmission of rabies during an outbreak (2010 - 2017) in Harare, Zimbabwe.
    PLoS One. 2019;14:e0210018.
    PubMed     Abstract available

  176. YOSHINO T, Miyazaki J, Kojima T, Kandori S, et al
    Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model.
    PLoS One. 2019;14:e0209196.
    PubMed     Abstract available

  177. Correction: BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0223903.
    PubMed     Abstract available

  178. ENERLY E, Flingtorp R, Christiansen IK, Campbell S, et al
    An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0223612.
    PubMed     Abstract available

  179. NAGANT C, Barbezange C, Dedeken L, Besse-Hammer T, et al
    Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.
    PLoS One. 2019;14:e0223991.
    PubMed     Abstract available

  180. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2019;14:e0223658.
    PubMed     Abstract available

  181. KATO H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, et al
    Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
    PLoS One. 2019;14:e0223684.
    PubMed     Abstract available

  182. AL-OMAR HA, Sherif HM, Mayet AY
    Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.
    PLoS One. 2019;14:e0223594.
    PubMed     Abstract available

  183. MARTINEZ-VEGA R, Jauneikaite E, Thoon KC, Chua HY, et al
    Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: A need to expand vaccination policy?
    PLoS One. 2019;14:e0220951.
    PubMed     Abstract available

  184. STAUFT CB, Yang C, Coleman JR, Boltz D, et al
    Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
    PLoS One. 2019;14:e0223784.
    PubMed     Abstract available

  185. BRADHURST R, Garner G, East I, Death C, et al
    Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.
    PLoS One. 2019;14:e0223518.
    PubMed     Abstract available

  186. WU CY, Yu SL, Chen YT, Chen YH, et al
    The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.
    PLoS One. 2019;14:e0210553.
    PubMed     Abstract available

  187. JIANG L, Tian X, Peng D, Zhang L, et al
    HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    PLoS One. 2019;14:e0210311.
    PubMed     Abstract available

  188. CLOTHIER HJ, Lawrie J, Russell MA, Kelly H, et al
    Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia.
    PLoS One. 2019;14:e0224702.
    PubMed     Abstract available

  189. KARLSSON LC, Lewandowsky S, Antfolk J, Salo P, et al
    The association between vaccination confidence, vaccination behavior, and willingness to recommend vaccines among Finnish healthcare workers.
    PLoS One. 2019;14:e0224330.
    PubMed     Abstract available

  190. HANSEN NS, Byberg S, Jacobsen LH, Bjerregaard-Andersen M, et al
    Correction: Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau.
    PLoS One. 2019;14:e0224782.
    PubMed     Abstract available

  191. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    PubMed     Abstract available

  192. LA TM, Choi EJ, Lee JB, Park SY, et al
    Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus.
    PLoS One. 2019;14:e0211158.
    PubMed     Abstract available

  193. COLAMESTA V, Tamburrano A, Barbara A, Gentili A, et al
    Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study.
    PLoS One. 2019;14:e0225326.
    PubMed     Abstract available

  194. KIL LP, Vaneman J, van der Lubbe JEM, Czapska-Casey D, et al
    Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice.
    PLoS One. 2019;14:e0225063.
    PubMed     Abstract available

  195. RYT-HANSEN P, Pedersen AG, Larsen I, Krog JS, et al
    Acute Influenza A virus outbreak in an enzootic infected sow herd: Impact on viral dynamics, genetic and antigenic variability and effect of maternally derived antibodies and vaccination.
    PLoS One. 2019;14:e0224854.
    PubMed     Abstract available

  196. IZQUIERDO-LARA R, Chumbe A, Calderon K, Fernandez-Diaz M, et al
    Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
    PLoS One. 2019;14:e0209539.
    PubMed     Abstract available

  197. LI C, Xu J, Deng Y, Sun H, et al
    Selection of reference genes for normalization of cranberry (Vaccinium macrocarpon Ait.) gene expression under different experimental conditions.
    PLoS One. 2019;14:e0224798.
    PubMed     Abstract available

  198. TARIMO EAM, Ambikile J, Munseri P, Bakari M, et al
    Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania.
    PLoS One. 2019;14:e0224831.
    PubMed     Abstract available

  199. ERCIBENGOA M, Alonso M, Vicente D, Morales M, et al
    Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping.
    PLoS One. 2019;14:e0212022.
    PubMed     Abstract available

  200. SHENGE JA, Odaibo GN, Olaleye DO
    Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria.
    PLoS One. 2019;14:e0210724.
    PubMed     Abstract available

  201. THIELMANN A, Puth MT, Kersting C, Porz J, et al
    Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study).
    PLoS One. 2019;14:e0224972.
    PubMed     Abstract available

  202. QI L, Su K, Xia Y, Tang W, et al
    Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017.
    PLoS One. 2019;14:e0225569.
    PubMed     Abstract available

  203. SISTERE-ORO M, Vergara-Alert J, Stratmann T, Lopez-Serrano S, et al
    Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
    PLoS One. 2019;14:e0212431.
    PubMed     Abstract available

  204. MIR RA, Schaut RG, Allen HK, Looft T, et al
    Cattle intestinal microbiota shifts following Escherichia coli O157:H7 vaccination and colonizationtravel.
    PLoS One. 2019;14:e0226099.
    PubMed     Abstract available

  205. THIELMANN A, Puth MT, Weltermann B
    Visual inspection of vaccine storage conditions in general practices: A study of 75 vaccine refrigerators.
    PLoS One. 2019;14:e0225764.
    PubMed     Abstract available

  206. Expression of Concern: Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
    PLoS One. 2019;14:e0226124.

  207. HEINSON AI, Ewing RM, Holloway JW, Woelk CH, et al
    An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction.
    PLoS One. 2019;14:e0226256.
    PubMed     Abstract available

  208. Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    PLoS One. 2019;14:e0226706.
    PubMed     Abstract available

  209. ABDO Z, LeCureux J, LaVoy A, Eklund B, et al
    Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice.
    PLoS One. 2019;14:e0225842.
    PubMed     Abstract available

  210. Correction: Cattle intestinal microbiota shifts following Escherichia coli O157:H7 vaccination and colonization.
    PLoS One. 2019;14:e0227403.
    PubMed     Abstract available

  211. COTE-GRAVEL J, Brouillette E, Malouin F
    Vaccination with a live-attenuated small-colony variant improves the humoral and cell-mediated responses against Staphylococcus aureus.
    PLoS One. 2019;14:e0227109.
    PubMed     Abstract available

  212. LOUKA C, Chandler E, Ranchor AV, Broer H, et al
    Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.
    PLoS One. 2019;14:e0226948.
    PubMed     Abstract available

  213. CRAM JA, Fiore-Gartland AJ, Srinivasan S, Karuna S, et al
    Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.
    PLoS One. 2019;14:e0225622.
    PubMed     Abstract available

  214. LATTHAPHASAVANG V, Vanhems P, Ngo-Giang-Huong N, Sibounlang P, et al
    Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study.
    PLoS One. 2019;14:e0215011.
    PubMed     Abstract available

  215. BLEVINS TP, Yu Y, Belshe RB, Bellamy AR, et al
    Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.
    PLoS One. 2019;14:e0214467.
    PubMed     Abstract available

  216. LI Y, Tang X, Zhao Z, Wang H, et al
    Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection.
    PLoS One. 2019;14:e0214596.
    PubMed     Abstract available

  217. ALHARBI A, Rabadi SM, Alqahtani M, Marghani D, et al
    Role of peroxiredoxin of the AhpC/TSA family in antioxidant defense mechanisms of Francisella tularensis.
    PLoS One. 2019;14:e0213699.
    PubMed     Abstract available

  218. SHIMBASHI R, Chang B, Tanabe Y, Takeda H, et al
    Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.
    PLoS One. 2019;14:e0212418.
    PubMed     Abstract available

  219. OLIVEIRA A, Selvaraj K, Tripathy JP, Betodkar U, et al
    Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India-A mixed methods operational research.
    PLoS One. 2019;14:e0226141.
    PubMed     Abstract available

  220. SEO H, Nandre RM, Nietfeld J, Chen Z, et al
    Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
    PLoS One. 2019;14:e0216076.
    PubMed     Abstract available

  221. ARZT J, Fish I, Pauszek SJ, Johnson SL, et al
    The evolution of a super-swarm of foot-and-mouth disease virus in cattle.
    PLoS One. 2019;14:e0210847.
    PubMed     Abstract available

  222. CHENG C, Xu K, Kong R, Chuang GY, et al
    Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
    PLoS One. 2019;14:e0215163.
    PubMed     Abstract available

  223. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam.
    PLoS One. 2019;14:e0208154.
    PubMed     Abstract available

  224. MATVEEV AL, Kozlova IV, Stronin OV, Khlusevich YA, et al
    Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
    PLoS One. 2019;14:e0215075.
    PubMed     Abstract available

  225. PATEL JS, Quates CJ, Johnson EL, Ytreberg FM, et al
    Expanding the watch list for potential Ebola virus antibody escape mutations.
    PLoS One. 2019;14:e0211093.
    PubMed     Abstract available

  226. RISTIC M, Milosevic V, Medic S, Djekic Malbasa J, et al
    Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.
    PLoS One. 2019;14:e0216219.
    PubMed     Abstract available

  227. PRABDIAL-SING N, Makhathini L, Smit SB, Manamela MJ, et al
    Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.
    PLoS One. 2019;14:e0217415.
    PubMed     Abstract available

  228. HOLMES CL, Peyton CG, Bier AM, Donlon TZ, et al
    Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.
    PLoS One. 2019;14:e0217221.
    PubMed     Abstract available

  229. AO Z, Wang L, Mendoza EJ, Cheng K, et al
    Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.
    PLoS One. 2019;14:e0216949.
    PubMed     Abstract available

  230. NDIZEYE Z, Vanden Broeck D, Lebelo RL, Bogers J, et al
    Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    PLoS One. 2019;14:e0209303.
    PubMed     Abstract available

  231. DE GIER B, van Kassel MN, Sanders EAM, van de Beek D, et al
    Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.
    PLoS One. 2019;14:e0216749.
    PubMed     Abstract available

  232. WANG L, Tan Y, Wei C, Zhang H, et al
    A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide.
    PLoS One. 2019;14:e0218427.
    PubMed     Abstract available

  233. STASHKO LA, Gacic-Dobo M, Dumolard LB, Danovaro-Holliday MC, et al
    Assessing the quality and accuracy of national immunization program reported target population estimates from 2000 to 2016.
    PLoS One. 2019;14:e0216933.
    PubMed     Abstract available

  234. CARDOSO AM, Resende PC, Paixao ES, Tavares FG, et al
    Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.
    PLoS One. 2019;14:e0218925.
    PubMed     Abstract available

  235. BHUIYAN MS, Hossain M, Sharmin S, Shirin A, et al
    Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS).
    PLoS One. 2019;14:e0218353.
    PubMed     Abstract available

  236. QURESHI S, Ahmad K, Fatima P, Hassan RM, et al
    Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
    PLoS One. 2019;14:e0219324.
    PubMed     Abstract available

  237. CAINI S, Kusznierz G, Garate VV, Wangchuk S, et al
    The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
    PLoS One. 2019;14:e0222381.
    PubMed     Abstract available

  238. WANG W, Vassell R, Song HS, Chen Q, et al
    Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
    PLoS One. 2019;14:e0222436.
    PubMed     Abstract available

  239. SABRI A, Quistrebert J, Naji Amrani H, Abid A, et al
    Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    PLoS One. 2019;14:e0221081.
    PubMed     Abstract available

  240. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam.
    PLoS One. 2019;14:e0223733.
    PubMed     Abstract available

  241. LIND A, Akel O, Wallenius M, Ramelius A, et al
    HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
    PLoS One. 2019;14:e0222882.
    PubMed     Abstract available

  242. KUROSAWA Y, Sato S, Okuyama T, Taoka M, et al
    Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns.
    PLoS One. 2019;14:e0222199.
    PubMed     Abstract available

  243. LAI CC, Weng TC, Tseng YF, Chiang JR, et al
    Evaluation of novel disposable bioreactors on pandemic influenza virus production.
    PLoS One. 2019;14:e0220803.
    PubMed     Abstract available

  244. POTTER GE, Wong J, Sugimoto J, Diallo A, et al
    Networks of face-to-face social contacts in Niakhar, Senegal.
    PLoS One. 2019;14:e0220443.
    PubMed     Abstract available

  245. HAU SJ, Mou KT, Bayles DO, Brockmeier SL, et al
    Transcriptomic differences noted in Glaesserella parasuis between growth in broth and on agar.
    PLoS One. 2019;14:e0220365.
    PubMed     Abstract available

  246. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    PubMed     Abstract available

  247. DUNNE EM, Choummanivong M, Neal EFG, Stanhope K, et al
    Factors associated with pneumococcal carriage and density in infants and young children in Laos PDR.
    PLoS One. 2019;14:e0224392.
    PubMed     Abstract available

  248. NJOUOM R, Monamele CG, Munshili Njifon HL, Kenmoe S, et al
    Circulation of influenza virus from 2009 to 2018 in Cameroon: 10 years of surveillance data.
    PLoS One. 2019;14:e0225793.
    PubMed     Abstract available

  249. CHANDRA J, Woo WP, Dutton JL, Xu Y, et al
    Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial.
    PLoS One. 2019;14:e0226320.
    PubMed     Abstract available

  250. WIJAYASRI S, Hillier K, Lim GH, Harris TM, et al
    The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.
    PLoS One. 2019;14:e0226353.
    PubMed     Abstract available

  251. TAPIA F, Wohlfarth D, Sandig V, Jordan I, et al
    Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    PLoS One. 2019;14:e0224317.
    PubMed     Abstract available

  252. NEJO YT, Olaleye DO, Odaibo GN
    Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria.
    PLoS One. 2019;14:e0224748.
    PubMed     Abstract available

  253. KING HAD, Gonelli CA, Tullett KM, Lahoud MH, et al
    Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting.
    PLoS One. 2019;14:e0220986.
    PubMed     Abstract available

    January 2018
  254. WU PW, Huang CC, Chao WC, Sun CC, et al
    Impact of influenza vaccine on childhood otitis media in Taiwan: A population-based study.
    PLoS One. 2018;13:e0190507.
    PubMed     Abstract available

  255. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0189571.
    PubMed     Abstract available

  256. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    PubMed     Abstract available

  257. ZUST R, Li SH, Xie X, Velumani S, et al
    Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants.
    PLoS One. 2018;13:e0189262.
    PubMed     Abstract available

  258. WALLACE RM, Lai Y, Doty JB, Chen CC, et al
    Initial pen and field assessment of baits to use in oral rabies vaccination of Formosan ferret-badgers in response to the re-emergence of rabies in Taiwan.
    PLoS One. 2018;13:e0189998.
    PubMed     Abstract available

  259. MBULAWA ZZA, van Schalkwyk C, Hu NC, Meiring TL, et al
    High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.
    PLoS One. 2018;13:e0190166.
    PubMed     Abstract available

  260. TARIGAN S, Wibowo MH, Indriani R, Sumarningsih S, et al
    Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    PLoS One. 2018;13:e0190947.
    PubMed     Abstract available

  261. CAROLAN K, Verran J, Crossley M, Redfern J, et al
    Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: A pilot study.
    PLoS One. 2018;13:e0190984.
    PubMed     Abstract available

  262. NOYCE RS, Lederman S, Evans DH
    Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.
    PLoS One. 2018;13:e0188453.
    PubMed     Abstract available

  263. HAMMAMI P, Lancelot R, Domenech J, Lesnoff M, et al
    Ex-ante assessment of different vaccination-based control schedules against the peste des petits ruminants virus in sub-Saharan Africa.
    PLoS One. 2018;13:e0190296.
    PubMed     Abstract available

  264. KIM AR, Lee DH, Lee SH, Rubino I, et al
    Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
    PLoS One. 2018;13:e0191277.
    PubMed     Abstract available

  265. FERNANDEZ-ARIAS C, Arias CF, Zhang M, Herrero MA, et al
    Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.
    PLoS One. 2018;13:e0190940.
    PubMed     Abstract available

  266. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Correction: Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2018;13:e0191378.
    PubMed     Abstract available

  267. LEE YT, Ko EJ, Lee Y, Kim KH, et al
    Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
    PLoS One. 2018;13:e0190868.
    PubMed     Abstract available

  268. BAUMGAERTNER B, Carlisle JE, Justwan F
    The influence of political ideology and trust on willingness to vaccinate.
    PLoS One. 2018;13:e0191728.
    PubMed     Abstract available

  269. KIM H, Kimoto T, Sakai S, Takahashi E, et al
    Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    PLoS One. 2018;13:e0191133.
    PubMed     Abstract available

  270. HARALAMBIEVA IH, Kennedy RB, Simon WL, Goergen KM, et al
    Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.
    PLoS One. 2018;13:e0191812.
    PubMed     Abstract available

  271. OPRIESSNIG T, Gauger PC, Gerber PF, Castro AMMG, et al
    Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.
    PLoS One. 2018;13:e0191739.
    PubMed     Abstract available

  272. ALLARD D, Charlebois R, Gilbert L, Stagg J, et al
    CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination.
    PLoS One. 2018;13:e0191973.
    PubMed     Abstract available

  273. TUTYKHINA I, Esmagambetov I, Bagaev A, Pichugin A, et al
    Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
    PLoS One. 2018;13:e0191574.
    PubMed     Abstract available

  274. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    PubMed     Abstract available

  275. SASAKI E, Momose H, Hiradate Y, Furuhata K, et al
    Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
    PLoS One. 2018;13:e0191896.
    PubMed     Abstract available

  276. GRANDAHL M, Chun Paek S, Grisurapong S, Sherer P, et al
    Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0193054.
    PubMed     Abstract available

  277. VERANI JR, Massora S, Acacio S, Dos Santos RT, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.
    PLoS One. 2018;13:e0191113.
    PubMed     Abstract available

  278. GIACOMET V, Masetti M, Nannini P, Forlanini F, et al
    Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults.
    PLoS One. 2018;13:e0192638.
    PubMed     Abstract available

  279. WILSON SE, Chung H, Schwartz KL, Guttmann A, et al
    Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.
    PLoS One. 2018;13:e0192809.
    PubMed     Abstract available

  280. BASKIN E
    Increasing influenza vaccination rates via low cost messaging interventions.
    PLoS One. 2018;13:e0192594.
    PubMed     Abstract available

  281. SHAH MP, Dahl RM, Parashar UD, Lopman BA, et al
    Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States.
    PLoS One. 2018;13:e0191429.
    PubMed     Abstract available

  282. HALL MT, Simms KT, Lew JB, Smith MA, et al
    Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
    PLoS One. 2018;13:e0185332.
    PubMed     Abstract available

  283. KAWAKAMI R, Nozato Y, Nakagami H, Ikeda Y, et al
    Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.
    PLoS One. 2018;13:e0191895.
    PubMed     Abstract available

  284. LEE RU, Won SH, Hansen C, Crum-Cianflone NF, et al
    25-hydroxyvitamin D, influenza vaccine response and healthcare encounters among a young adult population.
    PLoS One. 2018;13:e0192479.
    PubMed     Abstract available

  285. THORRINGTON D, van Rossum L, Knol M, de Melker H, et al
    Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.
    PLoS One. 2018;13:e0192640.
    PubMed     Abstract available

  286. BERKHOUT C, Willefert-Bouche A, Chazard E, Zgorska-Maynard-Moussa S, et al
    Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms.
    PLoS One. 2018;13:e0192155.
    PubMed     Abstract available

  287. NEWMAN LP, Bhat N, Fleming JA, Neuzil KM, et al
    Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.
    PLoS One. 2018;13:e0193263.
    PubMed     Abstract available

  288. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0192312.
    PubMed     Abstract available

  289. BISSA M, Forlani G, Zanotto C, Tosi G, et al
    Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes.
    PLoS One. 2018;13:e0190869.
    PubMed     Abstract available

  290. SIGAUQUE B, Kobayashi M, Vubil D, Nhacolo A, et al
    Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.
    PLoS One. 2018;13:e0191193.
    PubMed     Abstract available

  291. YOSHIKAWA T, Fujii H, Okutani A, Shibamura M, et al
    Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
    PLoS One. 2018;13:e0192725.
    PubMed     Abstract available

  292. Correction: Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2018;13:e0193631.
    PubMed     Abstract available

  293. WOOD PL, Steinman M, Erol E, Carter C, et al
    Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses.
    PLoS One. 2018;13:e0193424.
    PubMed     Abstract available

  294. SCHERER AM, Schacht Reisinger H, Schweizer ML, Askelson NM, et al
    Cross-sectional associations between psychological traits, and HPV vaccine uptake and intentions in young adults from the United States.
    PLoS One. 2018;13:e0193363.
    PubMed     Abstract available

  295. WHITE M, Freistaedter A, Jones GJB, Zervos E, et al
    Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
    PLoS One. 2018;13:e0193131.
    PubMed     Abstract available

  296. XU K, Zhao Q, Wen X, Wu R, et al
    A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.
    PLoS One. 2018;13:e0191286.
    PubMed     Abstract available

  297. MOR Z, Amit Aharon A, Sheffer R, Nehama H, et al
    Growth, developmental achievements and vaccines timeliness of undocumented migrant children from Eritrea compared with Israelis.
    PLoS One. 2018;13:e0193219.
    PubMed     Abstract available

  298. GONZALEZ-SANCHEZ ME, Cuquerella M, Alunda JM
    Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose.
    PLoS One. 2018;13:e0193118.
    PubMed     Abstract available

  299. YUEN WWY, Lee A, Chan PKS, Tran L, et al
    Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.
    PLoS One. 2018;13:e0194159.
    PubMed     Abstract available

  300. FERNANDO N, Natoli R, Racic T, Wooff Y, et al
    The use of the vaccinia virus complement control protein (VCP) in the rat retina.
    PLoS One. 2018;13:e0193740.
    PubMed     Abstract available

  301. EBRAHIMI-NIK H, Bassami MR, Mohri M, Rad M, et al
    Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
    PLoS One. 2018;13:e0194888.
    PubMed     Abstract available

  302. CASALINO E, Ghazali A, Bouzid D, Antoniol S, et al
    Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.
    PLoS One. 2018;13:e0193029.
    PubMed     Abstract available

  303. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    PubMed     Abstract available

  304. ANDREAE CA, Sessions RB, Virji M, Hill DJ, et al
    Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.
    PLoS One. 2018;13:e0193940.
    PubMed     Abstract available

  305. VISSERS M, Wijmenga-Monsuur AJ, Knol MJ, Badoux P, et al
    Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.
    PLoS One. 2018;13:e0194823.
    PubMed     Abstract available

  306. NAPOLITANO F, Navaro M, Vezzosi L, Santagati G, et al
    Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy.
    PLoS One. 2018;13:e0194920.
    PubMed     Abstract available

  307. HACHIYA M, Miyano S, Mori Y, Vynnycky E, et al
    Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    PLoS One. 2018;13:e0194931.
    PubMed     Abstract available

  308. SHAHID MA, Marenda MS, Markham PF, Noormohammadi AH, et al
    Complementation of the Mycoplasma synoviae MS-H vaccine strain with wild-type obg influencing its growth characteristics.
    PLoS One. 2018;13:e0194528.
    PubMed     Abstract available

  309. JANG H, Elaish M, Kc M, Abundo MC, et al
    Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    PLoS One. 2018;13:e0195285.
    PubMed     Abstract available

  310. GRAY DW, Welsh MD, Mansoor F, Doherty S, et al
    DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles.
    PLoS One. 2018;13:e0194488.
    PubMed     Abstract available

  311. TRAMUTO F, Maida CM, Pojero F, Colomba GME, et al
    Case-based surveillance of measles in Sicily during 2012-2017: The changing molecular epidemiology and implications for vaccine strategies.
    PLoS One. 2018;13:e0195256.
    PubMed     Abstract available

  312. RAJENDRAN M, Sun W, Comella P, Nachbagauer R, et al
    An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    PLoS One. 2018;13:e0194830.
    PubMed     Abstract available

  313. OVERTON ET, Lawrence SJ, Wagner E, Nopora K, et al
    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
    PLoS One. 2018;13:e0195897.
    PubMed     Abstract available

  314. SHERMAN SM, Nailer E
    Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK.
    PLoS One. 2018;13:e0195801.
    PubMed     Abstract available

  315. ZHOU JJ, Wang YM, Lee VWS, Zhang GY, et al
    DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    PLoS One. 2018;13:e0195657.
    PubMed     Abstract available

  316. WANG J, Hilchey SP, DeDiego M, Perry S, et al
    Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
    PLoS One. 2018;13:e0193680.
    PubMed     Abstract available

  317. GUARDO AC, Gomez CE, Diaz-Brito V, Pich J, et al
    Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2018;13:e0195915.
    PubMed     Abstract available

  318. GRANDAHL M, Paek SC, Grisurapong S, Sherer P, et al
    Correction: Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0196437.
    PubMed     Abstract available

  319. DAVIS CL, Wahid R, Toapanta FR, Simon JK, et al
    Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.
    PLoS One. 2018;13:e0196367.
    PubMed     Abstract available

  320. VAN RAVENHORST MB, den Hartog G, van der Klis FRM, van Rooijen DM, et al
    Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
    PLoS One. 2018;13:e0191261.
    PubMed     Abstract available

  321. MARLET J, Gaudy-Graffin C, Marc D, Boennec R, et al
    Factors associated with influenza vaccination failure and severe disease in a French region in 2015.
    PLoS One. 2018;13:e0195611.
    PubMed     Abstract available

  322. AKAPIRAT S, Karnasuta C, Vasan S, Rerks-Ngarm S, et al
    Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
    PLoS One. 2018;13:e0196397.
    PubMed     Abstract available

  323. TOVAR C, Patchett AL, Kim V, Wilson R, et al
    Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    PLoS One. 2018;13:e0196469.
    PubMed     Abstract available

  324. VOYSEY M, Pollard AJ, Perera R, Shrestha S, et al
    Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
    PLoS One. 2018;13:e0196200.
    PubMed     Abstract available

  325. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0196546.
    PubMed     Abstract available

  326. DORAN RC, Tatsuno GP, O'Rourke SM, Yu B, et al
    Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
    PLoS One. 2018;13:e0196370.
    PubMed     Abstract available

  327. MCCORMICK AA, Shakeel A, Yi C, Kaur H, et al
    Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    PLoS One. 2018;13:e0194614.
    PubMed     Abstract available

  328. GIL DE LOS SANTOS D, Gil de Los Santos JR, Gil-Turnes C, Gaboardi G, et al
    Probiotic effect of Pichia pastoris X-33 produced in parboiled rice effluent and YPD medium on broiler chickens.
    PLoS One. 2018;13:e0192904.
    PubMed     Abstract available

  329. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    PubMed     Abstract available

  330. KHAN A, Junaid M, Kaushik AC, Ali A, et al
    Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.
    PLoS One. 2018;13:e0196484.
    PubMed     Abstract available

  331. NUISMER SL, May R, Basinski A, Remien CH, et al
    Controlling epidemics with transmissible vaccines.
    PLoS One. 2018;13:e0196978.
    PubMed     Abstract available

  332. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Abstract available

  333. BUMGARDNER SA, Zhang L, LaVoy AS, Andre B, et al
    Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
    PLoS One. 2018;13:e0196950.
    PubMed     Abstract available

  334. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0196564.
    PubMed     Abstract available

  335. BORTHWICK NJ, Lane T, Moyo N, Crook A, et al
    Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    PLoS One. 2018;13:e0197299.
    PubMed     Abstract available

  336. PAULY M, Black AP, Khampanisong P, Nouanthong P, et al
    Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    PLoS One. 2018;13:e0197370.
    PubMed     Abstract available

  337. MARLEY KB, Kuehn LA, Keele JW, Wileman BW, et al
    Genetic variation in humoral response to an Escherichia coli O157:H7 vaccine in beef cattle.
    PLoS One. 2018;13:e0197347.
    PubMed     Abstract available

  338. MUELLER SW, Baumgartner LJ, MacLaren R, Neumann R, et al
    Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.
    PLoS One. 2018;13:e0197037.
    PubMed     Abstract available

  339. MANOHARAN VK, Varghese BP, Paldurai A, Samal SK, et al
    Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    PLoS One. 2018;13:e0197253.
    PubMed     Abstract available

  340. NEIRA V, Allerson M, Corzo C, Culhane M, et al
    Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.
    PLoS One. 2018;13:e0197600.
    PubMed     Abstract available

  341. HUANG Z, Sun X, Wagner AL, Ren J, et al
    Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China.
    PLoS One. 2018;13:e0197437.
    PubMed     Abstract available

  342. Correction: Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0198577.
    PubMed     Abstract available

  343. SELLENS E, Norris JM, Dhand NK, Heller J, et al
    Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.
    PLoS One. 2018;13:e0198421.
    PubMed     Abstract available

  344. ILYINSKII PO, Kovalev GI, O'Neil CP, Roy CJ, et al
    Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
    PLoS One. 2018;13:e0197694.
    PubMed     Abstract available

  345. SHENG X, Liu M, Liu H, Tang X, et al
    Identification of immunogenic proteins and evaluation of recombinant PDHA1 and GAPDH as potential vaccine candidates against Streptococcus iniae infection in flounder (Paralichthys olivaceus).
    PLoS One. 2018;13:e0195450.
    PubMed     Abstract available

  346. LIU M, Huang M, Shui Y, Biville F, et al
    Roles of B739_1343 in iron acquisition and pathogenesis in Riemerella anatipestifer CH-1 and evaluation of the RA-CH-1DeltaB739_1343 mutant as an attenuated vaccine.
    PLoS One. 2018;13:e0197310.
    PubMed     Abstract available

  347. CAYROU C, Akinduko AA, Mirkes EM, Lucidarme J, et al
    Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
    PLoS One. 2018;13:e0197186.
    PubMed     Abstract available

  348. KOOIJMAN S, Brummelman J, van Els CACM, Marino F, et al
    Vaccine antigens modulate the innate response of monocytes to Al(OH)3.
    PLoS One. 2018;13:e0197885.
    PubMed     Abstract available

  349. DE PASCALIS R, Hahn A, Brook HM, Ryden P, et al
    A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    PLoS One. 2018;13:e0198140.
    PubMed     Abstract available

  350. SOUTHERN J, Andrews N, Sandu P, Sheppard CL, et al
    Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
    PLoS One. 2018;13:e0195799.
    PubMed     Abstract available

  351. KUCHENBECKER U, Chase D, Reichert A, Schiffner-Rohe J, et al
    Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
    PLoS One. 2018;13:e0197905.
    PubMed     Abstract available

  352. IMAI C, Toizumi M, Hall L, Lambert S, et al
    A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    PLoS One. 2018;13:e0198685.
    PubMed     Abstract available

  353. SHAHRUDIN S, Chen C, David SC, Singleton EV, et al
    Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
    PLoS One. 2018;13:e0198182.
    PubMed     Abstract available

  354. POTTINGER HL, Jacobs ET, Haenchen SD, Ernst KC, et al
    Parental attitudes and perceptions associated with childhood vaccine exemptions in high-exemption schools.
    PLoS One. 2018;13:e0198655.
    PubMed     Abstract available

  355. MOHAMMED H, Clarke M, Koehler A, Watson M, et al
    Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
    PLoS One. 2018;13:e0197867.
    PubMed     Abstract available

  356. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    PubMed     Abstract available

  357. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    The views of the general public on prioritising vaccination programmes against childhood diseases: A qualitative study.
    PLoS One. 2018;13:e0197374.
    PubMed     Abstract available

  358. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Abstract available

  359. GROPPO R, DiNapoli J, Il Jeong K, Kishko M, et al
    Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
    PLoS One. 2018;13:e0199452.
    PubMed     Abstract available

  360. SU JR, Ng C, Lewis PW, Cano MV, et al
    Adverse events after vaccination among HIV-positive persons, 1990-2016.
    PLoS One. 2018;13:e0199229.
    PubMed     Abstract available

  361. CHIT A, Zivaripiran H, Shin T, Lee JKH, et al
    Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.
    PLoS One. 2018;13:e0197970.
    PubMed     Abstract available

  362. CHEUNG T, Lau JTF, Wang JZ, Mo PKH, et al
    Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong.
    PLoS One. 2018;13:e0198615.
    PubMed     Abstract available

  363. HORSINGTON J, Nfon C, Bittner H, Durr PA, et al
    The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.
    PLoS One. 2018;13:e0195302.
    PubMed     Abstract available

  364. DE SMEDT T, Merrall E, Macina D, Perez-Vilar S, et al
    Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    PLoS One. 2018;13:e0199180.
    PubMed     Abstract available

  365. NYARI S, Khan SA, Rawlinson G, Waugh CA, et al
    Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
    PLoS One. 2018;13:e0200112.
    PubMed     Abstract available

  366. WU AG, Shah AS, Haelle TS, Lunos SA, et al
    Choosing the perfect shot - The loaded narrative of imagery in online news coverage of vaccines.
    PLoS One. 2018;13:e0199870.
    PubMed     Abstract available

  367. ZARNITSYNA VI, Bulusheva I, Handel A, Longini IM, et al
    Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.
    PLoS One. 2018;13:e0199674.
    PubMed     Abstract available

  368. IMAI N, Ferguson NM
    Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design.
    PLoS One. 2018;13:e0199450.
    PubMed     Abstract available

  369. KARAMPATSAS K, Osborne L, Seah ML, Tong CYW, et al
    Clinical characteristics and complications of rotavirus gastroenteritis in children in east London: A retrospective case-control study.
    PLoS One. 2018;13:e0194009.
    PubMed     Abstract available

  370. PALING FP, Olsen K, Ohneberg K, Wolkewitz M, et al
    Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.
    PLoS One. 2018;13:e0193445.
    PubMed     Abstract available

  371. ANDERSON KB, Simasathien S, Watanaveeradej V, Weg AL, et al
    Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    PLoS One. 2018;13:e0193050.
    PubMed     Abstract available

  372. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0199249.
    PubMed     Abstract available

  373. SUBAIYA S, Tabu C, N'ganga J, Awes AA, et al
    Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    PLoS One. 2018;13:e0199786.
    PubMed     Abstract available

  374. SEKULOSKI S, Batzloff MR, Griffin P, Parsonage W, et al
    Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.
    PLoS One. 2018;13:e0198658.
    PubMed     Abstract available

  375. PORTER CK, Lynen A, Riddle MS, Talaat K, et al
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
    PLoS One. 2018;13:e0194325.
    PubMed     Abstract available

  376. LEE KS, Lee YR, Park SY, Oh IH, et al
    The economic burden of rotavirus infection in South Korea from 2009 to 2012.
    PLoS One. 2018;13:e0194120.
    PubMed     Abstract available

  377. JUNG M
    The effect of maternal decisional authority on children's vaccination in East Asia.
    PLoS One. 2018;13:e0200333.
    PubMed     Abstract available

  378. MARBAIX S, Peetermans WE, Verhaegen J, Annemans L, et al
    Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.
    PLoS One. 2018;13:e0199427.
    PubMed     Abstract available

  379. ABDUL-CADER MS, Amarasinghe A, Palomino-Tapia V, Ahmed-Hassan H, et al
    In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.
    PLoS One. 2018;13:e0193964.
    PubMed     Abstract available

  380. GENTILE A, Bakir J, Firpo V, Casanueva EV, et al
    PCV13 vaccination impact: A multicenter study of pneumonia in 10 pediatric hospitals in Argentina.
    PLoS One. 2018;13:e0199989.
    PubMed     Abstract available

  381. MERIKI HD, Tufon KA, Anong DN, Tony NJ, et al
    Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon.
    PLoS One. 2018;13:e0200157.
    PubMed     Abstract available

  382. WEN Y, Trinh HV, Linton CE, Tani C, et al
    Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    PLoS One. 2018;13:e0194266.
    PubMed     Abstract available

  383. GIBSON AD, Mazeri S, Lohr F, Mayer D, et al
    One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns.
    PLoS One. 2018;13:e0200942.
    PubMed     Abstract available

  384. SHEN K, Wasserman M, Liu D, Yang YH, et al
    Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China.
    PLoS One. 2018;13:e0201245.
    PubMed     Abstract available

  385. OMINDE M, Sande J, Ooko M, Bottomley C, et al
    Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya.
    PLoS One. 2018;13:e0200715.
    PubMed     Abstract available

  386. LEE HS, Thiem VD, Anh DD, Duong TN, et al
    Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015.
    PLoS One. 2018;13:e0194943.
    PubMed     Abstract available

  387. LIANG H, Yang R, Liu Z, Li M, et al
    Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    PLoS One. 2018;13:e0194860.
    PubMed     Abstract available

  388. KAUFMAN J, Ryan R, Hill S
    Qualitative focus groups with stakeholders identify new potential outcomes related to vaccination communication.
    PLoS One. 2018;13:e0201145.
    PubMed     Abstract available

  389. BAKER DL, Powers JG, Ransom JI, McCann BE, et al
    Reimmunization increases contraceptive effectiveness of gonadotropin-releasing hormone vaccine (GonaCon-Equine) in free-ranging horses (Equus caballus): Limitations and side effects.
    PLoS One. 2018;13:e0201570.
    PubMed     Abstract available

  390. LEE MF, Chiang CH, Li YL, Wang NM, et al
    Oral edible plant vaccine containing hypoallergen of American cockroach major allergen Per a 2 prevents roach-allergic asthma in a murine model.
    PLoS One. 2018;13:e0201281.
    PubMed     Abstract available

  391. MAZAGATOS C, Delgado-Sanz C, Oliva J, Gherasim A, et al
    Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    PLoS One. 2018;13:e0200934.
    PubMed     Abstract available

  392. MUNGUAMBE AM, de Almeida AECC, Nhantumbo AA, Come CE, et al
    Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    PLoS One. 2018;13:e0197390.
    PubMed     Abstract available

  393. PURRINOS-HERMIDA MJ, Santiago-Perez MI, Trevino M, Dopazo R, et al
    Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain.
    PLoS One. 2018;13:e0201653.
    PubMed     Abstract available

  394. BROWN DW, Tabu C, Sergon K, Shendale S, et al
    Home-based record (HBR) ownership and use of HBR recording fields in selected Kenyan communities: Results from the Kenya Missed Opportunities for Vaccination Assessment.
    PLoS One. 2018;13:e0201538.
    PubMed     Abstract available

  395. O'ROURKE SM, Byrne G, Tatsuno G, Wright M, et al
    Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
    PLoS One. 2018;13:e0197656.
    PubMed     Abstract available

  396. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    PubMed     Abstract available

  397. POSUWAN N, Vorayingyong A, Jaroonvanichkul V, Wasitthankasem R, et al
    Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    PLoS One. 2018;13:e0202637.
    PubMed     Abstract available

  398. RANFAING J, Dunyach-Remy C, Lavigne JP, Sotto A, et al
    Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli.
    PLoS One. 2018;13:e0202609.
    PubMed     Abstract available

  399. KLYZ A, Piekarowicz A
    Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates.
    PLoS One. 2018;13:e0202437.
    PubMed     Abstract available

  400. TSYBALOVA LM, Stepanova LA, Shuklina MA, Mardanova ES, et al
    Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    PLoS One. 2018;13:e0201429.
    PubMed     Abstract available

  401. MARITAN M, Veggi D, Cozzi R, Dello Iacono L, et al
    Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody.
    PLoS One. 2018;13:e0201922.
    PubMed     Abstract available

  402. AL MAHTAB M, Akbar SMF, Aguilar JC, Guillen G, et al
    Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).
    PLoS One. 2018;13:e0201236.
    PubMed     Abstract available

  403. Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2018;13:e0203635.

  404. MUNUSAMY PONNAN S, Swaminathan S, Tiruvengadam K, K K V, et al
    Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0203037.
    PubMed     Abstract available

  405. LI H, Hai Y, Lim SY, Toledo N, et al
    Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
    PLoS One. 2018;13:e0202997.
    PubMed     Abstract available

  406. SANAPALA S, Mosca L, Wang S, Curtiss R, et al
    Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence.
    PLoS One. 2018;13:e0203526.
    PubMed     Abstract available

  407. VOYSEY M, Sadarangani M, Pollard AJ, Fanshawe TR, et al
    Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias.
    PLoS One. 2018;13:e0202517.
    PubMed     Abstract available

  408. BOZIO CH, Abdul-Karim A, Abenyeri J, Abubakari B, et al
    Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2018;13:e0203205.
    PubMed     Abstract available

  409. HEGERLE N, Choi M, Sinclair J, Amin MN, et al
    Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    PLoS One. 2018;13:e0203143.
    PubMed     Abstract available

  410. MATTHIJSSE SM, Naber SK, Hontelez JAC, Bakker R, et al
    The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
    PLoS One. 2018;13:e0202924.
    PubMed     Abstract available

  411. LI J, Helal ZH, Karch CP, Mishra N, et al
    A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.
    PLoS One. 2018;13:e0203771.
    PubMed     Abstract available

  412. HOWLADER DR, Koley H, Sinha R, Maiti S, et al
    Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
    PLoS One. 2018;13:e0203631.
    PubMed     Abstract available

  413. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Abstract available

  414. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2018;13:e0204759.
    PubMed     Abstract available

  415. ELIZAGA ML, Li SS, Kochar NK, Wilson GJ, et al
    Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
    PLoS One. 2018;13:e0202753.
    PubMed     Abstract available

  416. Correction: Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.
    PLoS One. 2018;13:e0204476.
    PubMed     Abstract available

  417. BALOGUN F, Omotade O
    "She must have been sleeping around"...: Contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria.
    PLoS One. 2018;13:e0203950.
    PubMed     Abstract available

  418. ALLEN JD, Ray S, Ross TM
    Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0204284.
    PubMed     Abstract available

  419. ROSTAMIAN M, Bahrami F, Niknam HM
    Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    PLoS One. 2018;13:e0204491.
    PubMed     Abstract available

  420. SEMA BALTAZAR C, Rafael F, Langa JPM, Chicumbe S, et al
    Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    PLoS One. 2018;13:e0198592.
    PubMed     Abstract available

  421. SOBHKHEZ M, Krasnov A, Robertsen B
    Transcriptome analyses of Atlantic salmon muscle genes induced by a DNA vaccine against salmonid alphavirus, the causative agent of salmon pancreas disease (PD).
    PLoS One. 2018;13:e0204924.
    PubMed     Abstract available

  422. BAETEN LA, Podell BK, Sluder AE, Garritsen A, et al
    Standardized guinea pig model for Q fever vaccine reactogenicity.
    PLoS One. 2018;13:e0205882.
    PubMed     Abstract available

  423. LAU JTF, Ng CSM, Wu AMS, Ma YL, et al
    Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors.
    PLoS One. 2018;13:e0205561.
    PubMed     Abstract available

  424. DA SILVA EN, Baker A, Alshekaili J, Karpe K, et al
    A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.
    PLoS One. 2018;13:e0204477.
    PubMed     Abstract available

  425. TONUI T, Corredor-Moreno P, Kanduma E, Njuguna J, et al
    Transcriptomics reveal potential vaccine antigens and a drastic increase of upregulated genes during Theileria parva development from arthropod to bovine infective stages.
    PLoS One. 2018;13:e0204047.
    PubMed     Abstract available

  426. ISHIMURA ME, Teixeira D, Silveira GDP, Gambero M, et al
    Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.
    PLoS One. 2018;13:e0205148.
    PubMed     Abstract available

  427. WHELAN AO, Flick-Smith HC, Homan J, Shen ZT, et al
    Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
    PLoS One. 2018;13:e0200213.
    PubMed     Abstract available

  428. WADA H, Shimizu A, Osada T, Tanaka Y, et al
    Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
    PLoS One. 2018;13:e0205567.
    PubMed     Abstract available

  429. PARK S, Lee Y, Kwon YM, Lee YT, et al
    Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
    PLoS One. 2018;13:e0205071.
    PubMed     Abstract available

  430. LI Z, Swann JL, Keskinocak P
    Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    PLoS One. 2018;13:e0206293.
    PubMed     Abstract available

  431. JACKSON ML, Diallo AO, Medah I, Bicaba BW, et al
    Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.
    PLoS One. 2018;13:e0206117.
    PubMed     Abstract available

    System dynamics modelling approach to explore the effect of dog demography on rabies vaccination coverage in Africa.
    PLoS One. 2018;13:e0205884.
    PubMed     Abstract available

  433. CAMPBELL ZA, Marsh TL, Mpolya EA, Thumbi SM, et al
    Newcastle disease vaccine adoption by smallholder households in Tanzania: Identifying determinants and barriers.
    PLoS One. 2018;13:e0206058.
    PubMed     Abstract available

  434. O'MALLEY KJ, Bowling JL, Stinson E, Cole KS, et al
    Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0205928.
    PubMed     Abstract available

  435. HORACIO AN, Silva-Costa C, Lopes E, Ramirez M, et al
    Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
    PLoS One. 2018;13:e0206912.
    PubMed     Abstract available

  436. HOUSER KV, Yamshchikov GV, Bellamy AR, May J, et al
    DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
    PLoS One. 2018;13:e0206837.
    PubMed     Abstract available

  437. NYASANI DK, Mutua GN, Sajabi RM, Ng'ang'a JW, et al
    Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    PLoS One. 2018;13:e0206656.
    PubMed     Abstract available

  438. LI X, Doroshenko A, Osgood ND
    Applying particle filtering in both aggregated and age-structured population compartmental models of pre-vaccination measles.
    PLoS One. 2018;13:e0206529.
    PubMed     Abstract available

  439. CARTER SP, Robertson A, Palphramand KL, Chambers MA, et al
    Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis.
    PLoS One. 2018;13:e0206136.
    PubMed     Abstract available

  440. ZHAO H, Xu K, Jiang Z, Shao M, et al
    A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.
    PLoS One. 2018;13:e0207431.
    PubMed     Abstract available

  441. Correction: Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.
    PLoS One. 2018;13:e0207721.
    PubMed     Abstract available

  442. BECK KB, Honge BL, Olesen JS, Petersen MS, et al
    Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women.
    PLoS One. 2018;13:e0207259.
    PubMed     Abstract available

  443. JAIN A, Walker JL, Mathur R, Forbes HJ, et al
    Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink.
    PLoS One. 2018;13:e0207183.
    PubMed     Abstract available

  444. STEPHENSON KE, Keefer MC, Bunce CA, Frances D, et al
    First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
    PLoS One. 2018;13:e0205139.
    PubMed     Abstract available

  445. WONDIMENEH Y, Tiruneh M, Ferede G, Denekew K, et al
    Hospital based surveillance of congenital rubella syndrome cases in the pre-vaccine era in Amhara Regional State, Ethiopia: A base line information for the country.
    PLoS One. 2018;13:e0207095.
    PubMed     Abstract available

  446. ABU SEIR R, Azmi K, Hamdan A, Namouz H, et al
    Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
    PLoS One. 2018;13:e0206927.
    PubMed     Abstract available

  447. MENDES LOBAO W, Duarte FG, Burns JD, de Souza Teles Santos CA, et al
    Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?
    PLoS One. 2018;13:e0206726.
    PubMed     Abstract available

  448. MARX M, Zumpe M, Troschke-Meurer S, Shah D, et al
    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    PLoS One. 2018;13:e0207320.
    PubMed     Abstract available

  449. VIEGAS EO, Kroidl A, Munseri PJ, Missanga M, et al
    Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
    PLoS One. 2018;13:e0206838.
    PubMed     Abstract available

  450. CASSIOLATO AP, Almeida SCG, Andrade AL, Minamisava R, et al
    Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.
    PLoS One. 2018;13:e0208211.
    PubMed     Abstract available

  451. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    PubMed     Abstract available

  452. KHAN J, Shil A, Prakash R
    Exploring the spatial heterogeneity in different doses of vaccination coverage in India.
    PLoS One. 2018;13:e0207209.
    PubMed     Abstract available

  453. SONG IG, Lee H, Yi J, Kim MS, et al
    Health literacy and use of preventive health services among North Korean defectors in the Republic of Korea.
    PLoS One. 2018;13:e0195964.
    PubMed     Abstract available

  454. BARBOSA COSTA G, Gilbert A, Monroe B, Blanton J, et al
    The influence of poverty and rabies knowledge on healthcare seeking behaviors and dog ownership, Cameroon.
    PLoS One. 2018;13:e0197330.
    PubMed     Abstract available

  455. RAJAMOORTHY Y, Radam A, Taib NM, Rahim KA, et al
    The relationship between perceptions and self-paid hepatitis B vaccination: A structural equation modeling approach.
    PLoS One. 2018;13:e0208402.
    PubMed     Abstract available

  456. KORSA MG, Devlin JM, Hartley CA, Browning GF, et al
    Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens.
    PLoS One. 2018;13:e0207611.
    PubMed     Abstract available

  457. SONG JY, Noh JY, Lee JS, Wie SH, et al
    Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    PLoS One. 2018;13:e0207918.
    PubMed     Abstract available

  458. RUDENKO L, Kiseleva I, Krutikova E, Stepanova E, et al
    Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    PLoS One. 2018;13:e0208028.
    PubMed     Abstract available

  459. FLAMAR AL, Bonnabau H, Zurawski S, Lacabaratz C, et al
    HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
    PLoS One. 2018;13:e0207794.
    PubMed     Abstract available

  460. REN J, Wagner AL, Zheng A, Sun X, et al
    The demographics of vaccine hesitancy in Shanghai, China.
    PLoS One. 2018;13:e0209117.
    PubMed     Abstract available

  461. PASIN C, Halloran ME, Gilbert PB, Langevin E, et al
    Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
    PLoS One. 2018;13:e0207878.
    PubMed     Abstract available

  462. TIONO AB, Nebie I, Anagnostou N, Coulibaly AS, et al
    First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
    PLoS One. 2018;13:e0208328.
    PubMed     Abstract available

  463. SUNAGAR R, Kumar S, Namjoshi P, Rosa SJ, et al
    Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.
    PLoS One. 2018;13:e0207587.
    PubMed     Abstract available

  464. BETSCH C, Schmid P, Heinemeier D, Korn L, et al
    Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination.
    PLoS One. 2018;13:e0208601.
    PubMed     Abstract available

  465. ZHANG F, Zhao Q, Quan K, Zhu Z, et al
    Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    PLoS One. 2018;13:e0198207.
    PubMed     Abstract available

  466. KWAN NCL, Yamada A, Sugiura K
    Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan.
    PLoS One. 2018;13:e0206717.
    PubMed     Abstract available

  467. HAIWICK G, Hermann J, Roof M, Fergen B, et al
    Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study.
    PLoS One. 2018;13:e0209784.
    PubMed     Abstract available

  468. KESANOPOULOS K, Bratcher HB, Hong E, Xirogianni A, et al
    Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation.
    PLoS One. 2018;13:e0209919.
    PubMed     Abstract available

  469. ALLEN JD, Ray S, Ross TM
    Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0210043.
    PubMed     Abstract available

  470. AMPARO ACB, Jayme SI, Roces MCR, Quizon MCL, et al
    The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
    PLoS One. 2018;13:e0199186.
    PubMed     Abstract available

  471. DE NARDO P, Gentilotti E, Vairo F, Nguhuni B, et al
    A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination.
    PLoS One. 2018;13:e0197996.
    PubMed     Abstract available

  472. NUNES MC, Weinberg A, Cutland CL, Jones S, et al
    Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
    PLoS One. 2018;13:e0210124.
    PubMed     Abstract available

  473. DIMALA CA, Kika BT, Kadia BM, Blencowe H, et al
    Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
    PLoS One. 2018;13:e0209744.
    PubMed     Abstract available

  474. MAKUMBI F, Byabagambi J, Muwanika R, Kigozi G, et al
    Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda.
    PLoS One. 2018;13:e0209167.
    PubMed     Abstract available

  475. PAES W, Dowle A, Coldwell J, Leech A, et al
    The Chlamydia trachomatis PmpD adhesin forms higher order structures through disulphide-mediated covalent interactions.
    PLoS One. 2018;13:e0198662.
    PubMed     Abstract available

  476. THAKUR A, Andrea A, Mikkelsen H, Woodworth JS, et al
    Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.
    PLoS One. 2018;13:e0201253.
    PubMed     Abstract available

  477. HOSSAIN MU, Omar TM, Alam I, Das KC, et al
    Pathway based therapeutic targets identification and development of an interactive database CampyNIBase of Campylobacter jejuni RM1221 through non-redundant protein dataset.
    PLoS One. 2018;13:e0198170.
    PubMed     Abstract available

  478. JIANG H, Huai Y, Chen H, Uyeki TM, et al
    Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012.
    PLoS One. 2018;13:e0201312.
    PubMed     Abstract available

  479. NIX EB, Choi J, Anthes C, Gaultier GN, et al
    Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    PLoS One. 2018;13:e0201282.
    PubMed     Abstract available

  480. ACHARYA P, Kismul H, Mapatano MA, Hatloy A, et al
    Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
    PLoS One. 2018;13:e0202742.
    PubMed     Abstract available

  481. STADLER J, Naderer L, Beffort L, Ritzmann M, et al
    Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.
    PLoS One. 2018;13:e0203560.
    PubMed     Abstract available

  482. PILKERTON CS, Hobbs GR, Lilly C, Knox SS, et al
    Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy.
    PLoS One. 2018;13:e0203330.
    PubMed     Abstract available

  483. SARAIVA MMS, Moreira Filho ALB, Freitas Neto OC, Silva NMV, et al
    Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut.
    PLoS One. 2018;13:e0203158.
    PubMed     Abstract available

  484. IN HJ, Lim H, Lee JA, Lee SR, et al
    Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    PLoS One. 2018;13:e0202552.
    PubMed     Abstract available

  485. DODD CN, de Ridder M, Huang WT, Weibel D, et al
    Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    PLoS One. 2018;13:e0204799.
    PubMed     Abstract available

  486. CHONG KC, Hu P, Lau S, Jia KM, et al
    Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China.
    PLoS One. 2018;13:e0205339.
    PubMed     Abstract available

  487. CHUNG CJ, Cha SH, Grimm AL, Ajithdoss D, et al
    Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.
    PLoS One. 2018;13:e0203482.
    PubMed     Abstract available

  488. ADAMO G, Sturabotti G, Baccolini V, de Soccio P, et al
    Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    PLoS One. 2018;13:e0205147.
    PubMed     Abstract available

  489. ERDEM G, Singh AK, Brusnahan AJ, Moore AN, et al
    Pneumococcal colonization among tracheostomy tube dependent children.
    PLoS One. 2018;13:e0206305.
    PubMed     Abstract available

  490. MATHEW E, Zhu H, Connelly SM, Sullivan MA, et al
    Display of the HIV envelope protein at the yeast cell surface for immunogen development.
    PLoS One. 2018;13:e0205756.
    PubMed     Abstract available

  491. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    PubMed     Abstract available

  492. ALKIE TN, Yitbarek A, Taha-Abdelaziz K, Astill J, et al
    Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
    PLoS One. 2018;13:e0206324.
    PubMed     Abstract available

  493. DEBELLUT F, Hendrix N, Ortiz JR, Lambach P, et al
    Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.
    PLoS One. 2018;13:e0199470.
    PubMed     Abstract available

  494. LAINO J, Villena J, Suvorov A, Zelaya H, et al
    Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    PLoS One. 2018;13:e0206661.
    PubMed     Abstract available

  495. MANNA S, Dunne EM, Ortika BD, Pell CL, et al
    Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene.
    PLoS One. 2018;13:e0206622.
    PubMed     Abstract available

  496. YIN R, Tran VH, Zhou X, Zheng J, et al
    Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model.
    PLoS One. 2018;13:e0207777.
    PubMed     Abstract available

  497. VAN DIEPEN MT, Chapman R, Moore PL, Margolin E, et al
    The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.
    PLoS One. 2018;13:e0208310.
    PubMed     Abstract available

  498. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
    PLoS One. 2018;13:e0208267.
    PubMed     Abstract available

  499. MORALES M, Ludwig G, Ercibengoa M, Esteva C, et al
    Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain.
    PLoS One. 2018;13:e0209048.
    PubMed     Abstract available

  500. MCSHERRY LA, O'Leary E, Dombrowski SU, Francis JJ, et al
    Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives.
    PLoS One. 2018;13:e0208482.
    PubMed     Abstract available

    January 2017
  501. JIA B, McNeil LK, Dupont CD, Tsioris K, et al
    Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
    PLoS One. 2017;12:e0183738.
    PubMed     Abstract available

  502. KANEKO M, Takanashi S, Thongprachum A, Hanaoka N, et al
    Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.
    PLoS One. 2017;12:e0184067.
    PubMed     Abstract available

  503. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    PubMed     Abstract available

  504. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Abstract available

  505. FRAIBERK M, Hajkova M, Krulova M, Kojzarova M, et al
    Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
    PLoS One. 2017;12:e0184870.
    PubMed     Abstract available

  506. LUEDERS I, Young D, Maree L, van der Horst G, et al
    Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality.
    PLoS One. 2017;12:e0178270.
    PubMed     Abstract available

  507. EVANGELISTA KV, Lourdault K, Matsunaga J, Haake DA, et al
    Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    PLoS One. 2017;12:e0180004.
    PubMed     Abstract available

  508. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Abstract available

  509. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Abstract available

  510. SARTORI AL, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.
    PLoS One. 2017;12:e0179222.
    PubMed     Abstract available

  511. PIPKINS HR, Bradshaw JL, Keller LE, Swiatlo E, et al
    Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    PLoS One. 2017;12:e0179159.
    PubMed     Abstract available

  512. BYBERG S, Ostergaard MD, Rodrigues A, Martins C, et al
    Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
    PLoS One. 2017;12:e0177984.
    PubMed     Abstract available

  513. WANG G, Yin R, Zhou P, Ding Z, et al
    Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    PLoS One. 2017;12:e0176854.
    PubMed     Abstract available

  514. VINOD N, Noh HB, Oh S, Ji S, et al
    A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.
    PLoS One. 2017;12:e0185488.
    PubMed     Abstract available

  515. FABURAY B, McGill J, Jongejan F
    A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.
    PLoS One. 2017;12:e0185495.
    PubMed     Abstract available

  516. GRIMALDI G JR, Teva A, Dos-Santos CB, Santos FN, et al
    Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    PLoS One. 2017;12:e0185438.
    PubMed     Abstract available

  517. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    PubMed     Abstract available

  518. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Abstract available

  519. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    PubMed     Abstract available

  520. HSU AP, Tseng CH, Barrat J, Lee SH, et al
    Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers.
    PLoS One. 2017;12:e0184831.
    PubMed     Abstract available

  521. CAPUCCI S, Wee EG, Schiffner T, LaBranche CC, et al
    HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
    PLoS One. 2017;12:e0181886.
    PubMed     Abstract available

  522. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    PubMed     Abstract available

  523. PEREZ LG, Martinez DR, deCamp AC, Pinter A, et al
    V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
    PLoS One. 2017;12:e0180720.
    PubMed     Abstract available

  524. MINAYA MA, Korom M, Wang H, Belshe RB, et al
    The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.
    PLoS One. 2017;12:e0176687.
    PubMed     Abstract available

  525. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    PubMed     Abstract available

  526. FERREYRA-REYES L, Cruz-Hervert LP, Troy SB, Huang C, et al
    Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.
    PLoS One. 2017;12:e0185594.
    PubMed     Abstract available

  527. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    PubMed     Abstract available

  528. WARD PR, Attwell K, Meyer SB, Rokkas P, et al
    Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: A qualitative study in Australia.
    PLoS One. 2017;12:e0185955.
    PubMed     Abstract available

  529. BILLARD MN, De Serres G, Gariepy MC, Boulianne N, et al
    Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
    PLoS One. 2017;12:e0186070.
    PubMed     Abstract available

  530. MCCURLEY NP, Domi A, Basu R, Saunders KO, et al
    HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
    PLoS One. 2017;12:e0177863.
    PubMed     Abstract available

  531. SMITH SG, Harris SA, Satti I, Bryan D, et al
    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.
    PLoS One. 2017;12:e0184391.
    PubMed     Abstract available

  532. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    PubMed     Abstract available

  533. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    PubMed     Abstract available

  534. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Abstract available

  535. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    PubMed     Abstract available

  536. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Abstract available

  537. HIGGINS JL, Gonzalez-Juarrero M, Bowen RA
    Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    PLoS One. 2017;12:e0185823.
    PubMed     Abstract available

  538. VAN DEN BIGGELAAR AHJ, Richmond PC, Fuery A, Anderson D, et al
    Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
    PLoS One. 2017;12:e0185877.
    PubMed     Abstract available

  539. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    PubMed     Abstract available

  540. CLARK A, Black R, Tate J, Roose A, et al
    Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
    PLoS One. 2017;12:e0183392.
    PubMed     Abstract available

  541. TI J, Li Z, Li X, Lu Y, et al
    Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
    PLoS One. 2017;12:e0181177.
    PubMed     Abstract available

  542. C GUARDO A, Gomez CE, Diaz-Brito V, Pich J, et al
    Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2017;12:e0186602.
    PubMed     Abstract available

  543. KAZADI EK, Tshilenge GM, Mbao V, Njoumemi Z, et al
    Determinants of dog owner-charged rabies vaccination in Kinshasa, Democratic Republic of Congo.
    PLoS One. 2017;12:e0186677.
    PubMed     Abstract available

  544. MONAMELE GC, Vernet MA, Njankouo MR, Victoir K, et al
    Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2017;12:e0184411.
    PubMed     Abstract available

  545. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    PubMed     Abstract available

  546. ROSE J, Homa L, Meropol SB, Debanne SM, et al
    Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    PLoS One. 2017;12:e0187446.
    PubMed     Abstract available

  547. GRANDAHL M, Larsson M, Dalianis T, Stenhammar C, et al
    Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.
    PLoS One. 2017;12:e0187193.
    PubMed     Abstract available

  548. DIALLO AO, Soeters HM, Yameogo I, Sawadogo G, et al
    Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    PLoS One. 2017;12:e0187466.
    PubMed     Abstract available

  549. ABIR T, Ogbo FA, Stevens GJ, Page AN, et al
    The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
    PLoS One. 2017;12:e0187090.
    PubMed     Abstract available

  550. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    PubMed     Abstract available

  551. CAFIERO-FONSECA ET, Stawasz A, Johnson ST, Sato R, et al
    The full benefits of adult pneumococcal vaccination: A systematic review.
    PLoS One. 2017;12:e0186903.
    PubMed     Abstract available

  552. CIONCADA R, Maddaluno M, Vo HTM, Woodruff M, et al
    Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    PLoS One. 2017;12:e0185843.
    PubMed     Abstract available

  553. FURUKAWA K, Tanemura M, Miyoshi E, Eguchi H, et al
    A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes.
    PLoS One. 2017;12:e0184901.
    PubMed     Abstract available

  554. SASTRY M, Zhang B, Chen M, Joyce MG, et al
    Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
    PLoS One. 2017;12:e0186854.
    PubMed     Abstract available

  555. LI H, Nykoluk M, Li L, Liu LR, et al
    Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0186079.
    PubMed     Abstract available

  556. FABIANI M, Ferrante G, Minardi V, Giambi C, et al
    Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015).
    PLoS One. 2017;12:e0178122.
    PubMed     Abstract available

  557. SORIA I, Quattrocchi V, Langellotti C, Gammella M, et al
    Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.
    PLoS One. 2017;12:e0185184.
    PubMed     Abstract available

  558. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Abstract available

  559. SAMIAK L, Emeto TI
    Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2017;12:e0187796.
    PubMed     Abstract available

  560. ALVAREZ-ZUZEK LG, La Rocca CE, Iglesias JR, Braunstein LA, et al
    Epidemic spreading in multiplex networks influenced by opinion exchanges on vaccination.
    PLoS One. 2017;12:e0186492.
    PubMed     Abstract available

  561. OKU A, Oyo-Ita A, Glenton C, Fretheim A, et al
    Perceptions and experiences of childhood vaccination communication strategies among caregivers and health workers in Nigeria: A qualitative study.
    PLoS One. 2017;12:e0186733.
    PubMed     Abstract available

  562. JAMAL SB, Hassan SS, Tiwari S, Viana MV, et al
    An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriae.
    PLoS One. 2017;12:e0186401.
    PubMed     Abstract available

  563. DECAMP AC, Rolland M, Edlefsen PT, Sanders-Buell E, et al
    Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
    PLoS One. 2017;12:e0185959.
    PubMed     Abstract available

  564. BUCHAN SA, Chung H, Campitelli MA, Crowcroft NS, et al
    Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.
    PLoS One. 2017;12:e0187834.
    PubMed     Abstract available

  565. HARALAMBIEVA IH, Gibson MJ, Kennedy RB, Ovsyannikova IG, et al
    Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
    PLoS One. 2017;12:e0188149.
    PubMed     Abstract available

  566. DE BRUYN J, Thomson PC, Bagnol B, Maulaga W, et al
    The chicken or the egg? Exploring bi-directional associations between Newcastle disease vaccination and village chicken flock size in rural Tanzania.
    PLoS One. 2017;12:e0188230.
    PubMed     Abstract available

  567. SOBHKHEZ M, Krasnov A, Chang CJ, Robertsen B, et al
    Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus.
    PLoS One. 2017;12:e0188456.
    PubMed     Abstract available

  568. SENAPATI R, Nayak B, Kar SK, Dwibedi B, et al
    HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    PLoS One. 2017;12:e0187844.
    PubMed     Abstract available

  569. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Abstract available

  570. RALEIGH MD, Peterson SJ, Laudenbach M, Baruffaldi F, et al
    Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
    PLoS One. 2017;12:e0184876.
    PubMed     Abstract available

  571. BOMMANA S, Walker E, Desclozeaux M, Timms P, et al
    Humoral immune response against two surface antigens of Chlamydia pecorum in vaccinated and naturally infected sheep.
    PLoS One. 2017;12:e0188370.
    PubMed     Abstract available

  572. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2017;12:e0184540.
    PubMed     Abstract available

  573. KUZNIK A, Iliyasu G, Lamorde M, Mahmud M, et al
    Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    PLoS One. 2017;12:e0188595.
    PubMed     Abstract available

  574. Correction: Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    PLoS One. 2017;12:e0189039.
    PubMed     Abstract available

  575. PRAPHASIRI P, Ditsungnoen D, Sirilak S, Rattanayot J, et al
    Predictors of seasonal influenza vaccination among older adults in Thailand.
    PLoS One. 2017;12:e0188422.
    PubMed     Abstract available

  576. CAYATTE C, Snell Bennett A, Rajani GM, Hostetler L, et al
    Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
    PLoS One. 2017;12:e0188708.
    PubMed     Abstract available

  577. CHAISRI U, Tungtrongchitr A, Indrawattana N, Meechan P, et al
    Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.
    PLoS One. 2017;12:e0188627.
    PubMed     Abstract available

  578. XING J, Singh S, Zhao Y, Duan Y, et al
    Increasing vaccine production using pulsed ultrasound waves.
    PLoS One. 2017;12:e0187048.
    PubMed     Abstract available

  579. MEUNIER M, Guyard-Nicodeme M, Vigouroux E, Poezevara T, et al
    Promising new vaccine candidates against Campylobacter in broilers.
    PLoS One. 2017;12:e0188472.
    PubMed     Abstract available

  580. MURRAY J, Todd KV, Bakre A, Orr-Burks N, et al
    A universal mammalian vaccine cell line substrate.
    PLoS One. 2017;12:e0188333.
    PubMed     Abstract available

  581. BRUXELLE JF, Mizrahi A, Hoys S, Collignon A, et al
    Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    PLoS One. 2017;12:e0187212.
    PubMed     Abstract available

  582. JEE PF, Tiong V, Shu MH, Khoo JJ, et al
    Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    PLoS One. 2017;12:e0187718.
    PubMed     Abstract available

  583. LIM J, Kim K, Choi S, Park SM, et al
    The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    PLoS One. 2017;12:e0189210.
    PubMed     Abstract available

  584. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2017;12:e0188807.
    PubMed     Abstract available

  585. KIM YG, Baltabekova AZ, Zhiyenbay EE, Aksambayeva AS, et al
    Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector.
    PLoS One. 2017;12:e0189308.
    PubMed     Abstract available

  586. RAJARAM S, Wiecek W, Lawson R, Blak BT, et al
    Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    PLoS One. 2017;12:e0186739.
    PubMed     Abstract available

  587. ARCURI M, Di Benedetto R, Cunningham AF, Saul A, et al
    The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
    PLoS One. 2017;12:e0189100.
    PubMed     Abstract available

  588. MWILA-KAZIMBAYA K, Garcia MP, Bosomprah S, Laban NM, et al
    Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia.
    PLoS One. 2017;12:e0189351.
    PubMed     Abstract available

  589. PLACE DE, Williamson DR, Yuzefpolskiy Y, Katkere B, et al
    Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.
    PLoS One. 2017;12:e0190384.
    PubMed     Abstract available

  590. MCMORROW ML, Emukule GO, Obor D, Nyawanda B, et al
    Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants?
    PLoS One. 2017;12:e0189623.
    PubMed     Abstract available

  591. MWAPE I, Bosomprah S, Mwaba J, Mwila-Kazimbaya K, et al
    Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
    PLoS One. 2017;12:e0187761.
    PubMed     Abstract available

  592. ZORENC Z, Veberic R, Slatnar A, Koron D, et al
    A wild 'albino' bilberry (Vaccinium myrtillus L.) from Slovenia shows three bottlenecks in the anthocyanin pathway and significant differences in the expression of several regulatory genes compared to the common blue berry type.
    PLoS One. 2017;12:e0190246.
    PubMed     Abstract available

  593. KODAY MT, Leonard JA, Munson P, Forero A, et al
    Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
    PLoS One. 2017;12:e0189780.
    PubMed     Abstract available

  594. TARTOF S, Cohn A, Tarbangdo F, Djingarey MH, et al
    Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt.
    PLoS One. 2017;12:e0190188.
    PubMed     Abstract available

  595. SUNTRONWONG N, Klinfueng S, Vichiwattana P, Korkong S, et al
    Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    PLoS One. 2017;12:e0189511.
    PubMed     Abstract available

  596. IKEGAMI T, Balogh A, Nishiyama S, Lokugamage N, et al
    Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.
    PLoS One. 2017;12:e0189250.
    PubMed     Abstract available

  597. BENNETT A, Nagelkerke N, Heinsbroek E, Premkumar PS, et al
    Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres.
    PLoS One. 2017;12:e0190256.
    PubMed     Abstract available

  598. PECENKA C, Munthali S, Chunga P, Levin A, et al
    Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.
    PLoS One. 2017;12:e0190006.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.